AXA/2025/FY/Financial supplement: Difference between revisions
Appearance
< AXA
Content deleted Content added
doc_archive: publish gr2rpazfcv Tag: Reverted |
Index sections (topic tags) Tag: Manual revert |
||
| (11 intermediate revisions by the same user not shown) | |||
| Line 4: | Line 4: | ||
| period = FY |
| period = FY |
||
| period_label = FY25 |
| period_label = FY25 |
||
| |
| document_category = Financial supplement |
||
| document_name = AXA FY 2025 Financial Supplement (Excel) |
| document_name = AXA FY 2025 Financial Supplement (Excel) |
||
| publication_date = 2026-02-26 |
| publication_date = 2026-02-26 |
||
| language = English |
| language = English |
||
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_KkMFoBIGEg14b_AXA_Financial_Supplement_2025_synthesis.xlsx |
| source_url = https://www-axa-com.cdn.prismic.io/www-axa-com/aZ_KkMFoBIGEg14b_AXA_Financial_Supplement_2025_synthesis.xlsx |
||
| archive_file = |
| archive_file = File:AXA-2025-FY-Financial_supplement.md |
||
| intro_sentence = This article presents AXA's FY 2025 financial supplement — the detailed data tables behind the period's results. |
| intro_sentence = This article presents AXA's FY 2025 financial supplement — the detailed data tables behind the period's results. |
||
}} |
}} |
||
| Line 16: | Line 16: | ||
== Market Data == |
== Market Data == |
||
{{Indexing|Exchange rate by currency|Exchange rates, USD, JPY, GBP, CHF, HKD|2g0bi52xlo|kind=table|order=1}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Exchange rate by currency |
|||
! style="text-align:left" | — |
! style="text-align:left" | — |
||
! class="col-s" style="text-align:right" | 1H24 |
! class="col-s" style="text-align:right" | 1H24 |
||
| Line 81: | Line 82: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Discount rate 5Y by currency|Discount rates, 5-year, EUR, USD, JPY, GBP, CHF, HKD|8057i7ggjm|kind=table|order=2}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Discount rate 5Y by currency |
|||
! style="text-align:left" | % |
! style="text-align:left" | % |
||
! class="col-s" style="text-align:right" | Average 1H24 |
! class="col-s" style="text-align:right" | Average 1H24 |
||
| Line 128: | Line 130: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Discount rate 10Y by currency|Discount rates, 10-year, EUR, USD, JPY, GBP, CHF, HKD|8057i7ggjm|kind=table|order=3}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Discount rate 10Y by currency |
|||
! style="text-align:left" | % |
! style="text-align:left" | % |
||
! class="col-s" style="text-align:right" | Closing 1H24 |
! class="col-s" style="text-align:right" | Closing 1H24 |
||
| Line 177: | Line 180: | ||
== UE by LOB and Net Income == |
== UE by LOB and Net Income == |
||
{{Indexing|Group underlying earnings and net income build-up by line of business|Underlying earnings, net income, Property & Casualty, Life & Health, Asset Management, Holdings|pw41e8kn7m|kind=table|order=4}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Group underlying earnings and net income build-up by line of business |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="4" style="text-align:center" | Group |
! colspan="4" style="text-align:center" | Group |
||
| Line 829: | Line 833: | ||
== UE by Geography == |
== UE by Geography == |
||
{{Indexing|Underlying earnings build-up by geography|Underlying earnings, France, Europe, AXA XL, Asia, Africa & EME-LATAM, AXA IM, Transversal & Other|iycymgpuon|kind=table|order=5}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Underlying earnings build-up by geography |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="4" style="text-align:center" | Group |
! colspan="4" style="text-align:center" | Group |
||
| Line 1,383: | Line 1,388: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Underlying earnings by line of business and geography|Underlying earnings, France, Europe, AXA XL, Asia, Africa & EME-LATAM, AXA IM, Transversal & Other, Property & Casualty, Life & Health, Asset Management, Holdings|iycymgpuon|pw41e8kn7m|kind=table|order=6}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Underlying earnings by line of business and geography |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="4" style="text-align:center" | Group |
! colspan="4" style="text-align:center" | Group |
||
| Line 1,579: | Line 1,585: | ||
== Shares & UEPS == |
== Shares & UEPS == |
||
{{Indexing|Basic number of shares rollforward|Outstanding shares, weighted average number of shares, capital increase, stock options, treasury shares|ch7st6ifed|kind=table|order=7}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Basic number of shares rollforward |
|||
! style="text-align:left" | |
! style="text-align:left" | |
||
! colspan="2" style="text-align:center" | Outstanding Shares Excluding Treasury Shares {{footnote|1=Under IFRS, Treasury shares are not considered as outstanding shares. Treasury shares amounted to 35 million shares as of FY25 and 39 million shares as of FY24.}} |
! colspan="2" style="text-align:center" | Outstanding Shares Excluding Treasury Shares {{footnote|1=Under IFRS, Treasury shares are not considered as outstanding shares. Treasury shares amounted to 35 million shares as of FY25 and 39 million shares as of FY24.}} |
||
| Line 1,734: | Line 1,741: | ||
== P&C UE by Sub LOB == |
== P&C UE by Sub LOB == |
||
{{Indexing|Property & casualty underlying earnings build-up by line of business|Property & Casualty underlying earnings, Commercial lines, Personal lines, AXA XL Reinsurance|pw41e8kn7m|kind=table|order=8}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Property & casualty underlying earnings build-up by line of business |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="4" style="text-align:center" | Total |
! colspan="4" style="text-align:center" | Total |
||
| Line 1,833: | Line 1,841: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Undiscounted Current Accident Year Loss Ratio (excl. Nat Cats) |
||
| style="text-align:right" | 67.4% |
| style="text-align:right" | 67.4% |
||
| style="text-align:right" | 67.4% |
| style="text-align:right" | 67.4% |
||
| Line 1,855: | Line 1,863: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Undiscounted Current Accident Year Nat Cats |
||
| style="text-align:right" | 3.6% |
| style="text-align:right" | 3.6% |
||
| style="text-align:right" | 3.8% |
| style="text-align:right" | 3.8% |
||
| Line 1,877: | Line 1,885: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Current Accident Year Discounting |
||
| style="text-align:right" | -3.9% |
| style="text-align:right" | -3.9% |
||
| style="text-align:right" | -3.6% |
| style="text-align:right" | -3.6% |
||
| Line 2,097: | Line 2,105: | ||
| style="text-align:right" | -20 |
| style="text-align:right" | -20 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Investment Income |
||
| style="text-align:right" | 1,967 |
| style="text-align:right" | 1,967 |
||
| style="text-align:right" | 3,731 |
| style="text-align:right" | 3,731 |
||
| Line 2,119: | Line 2,127: | ||
| style="text-align:right" | -20 |
| style="text-align:right" | -20 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Insurance Finance Expenses |
||
| style="text-align:right" | -643 |
| style="text-align:right" | -643 |
||
| style="text-align:right" | -1,172 |
| style="text-align:right" | -1,172 |
||
| Line 2,339: | Line 2,347: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w VFA |
||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
| Line 2,361: | Line 2,369: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w Non VFA |
||
| style="text-align:right" | 113,515 |
| style="text-align:right" | 113,515 |
||
| style="text-align:right" | 118,104 |
| style="text-align:right" | 118,104 |
||
| Line 2,452: | Line 2,460: | ||
== P&C UE by Geography == |
== P&C UE by Geography == |
||
{{Indexing|Property & casualty underlying earnings build-up by geography|Property & Casualty underlying earnings, France, Europe, AXA XL, Asia, Africa & EME-LATAM, Transversal & Other|iycymgpuon|kind=table|order=9}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Property & casualty underlying earnings build-up by geography |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="4" style="text-align:center" | Total |
! colspan="4" style="text-align:center" | Total |
||
| Line 2,584: | Line 2,593: | ||
| style="text-align:right" | 44.6% |
| style="text-align:right" | 44.6% |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Undiscounted Current Accident Year Loss Ratio (excl. Nat Cats) |
||
| style="text-align:right" | 67.4% |
| style="text-align:right" | 67.4% |
||
| style="text-align:right" | 67.4% |
| style="text-align:right" | 67.4% |
||
| Line 2,614: | Line 2,623: | ||
| style="text-align:right" | 44.5% |
| style="text-align:right" | 44.5% |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Undiscounted Current Accident Year Nat Cats |
||
| style="text-align:right" | 3.6% |
| style="text-align:right" | 3.6% |
||
| style="text-align:right" | 3.8% |
| style="text-align:right" | 3.8% |
||
| Line 2,644: | Line 2,653: | ||
| style="text-align:right" | 1.2% |
| style="text-align:right" | 1.2% |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Current Accident Year Discounting |
||
| style="text-align:right" | -3.9% |
| style="text-align:right" | -3.9% |
||
| style="text-align:right" | -3.6% |
| style="text-align:right" | -3.6% |
||
| Line 3,337: | Line 3,346: | ||
== L&H UE by LOB == |
== L&H UE by LOB == |
||
{{Indexing|Life & health underlying earnings build-up by line of business|Life & Health underlying earnings, Life, Health, Employee Benefits|pw41e8kn7m|kind=table|order=10}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Life & health underlying earnings build-up by line of business |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="4" style="text-align:center" | Total |
! colspan="4" style="text-align:center" | Total |
||
| Line 3,491: | Line 3,501: | ||
| style="text-align:right" | 38 |
| style="text-align:right" | 38 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Actual vs. Expected Cash Flows |
||
| style="text-align:right" | 9 |
| style="text-align:right" | 9 |
||
| style="text-align:right" | -15 |
| style="text-align:right" | -15 |
||
| Line 3,509: | Line 3,519: | ||
| style="text-align:right" | -8 |
| style="text-align:right" | -8 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Risk Adjustment Release |
||
| style="text-align:right" | 30 |
| style="text-align:right" | 30 |
||
| style="text-align:right" | 59 |
| style="text-align:right" | 59 |
||
| Line 3,527: | Line 3,537: | ||
| style="text-align:right" | 8 |
| style="text-align:right" | 8 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Changes in Onerous Contracts |
||
| style="text-align:right" | -32 |
| style="text-align:right" | -32 |
||
| style="text-align:right" | 6 |
| style="text-align:right" | 6 |
||
| Line 3,545: | Line 3,555: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Other Long-term |
||
| style="text-align:right" | -72 |
| style="text-align:right" | -72 |
||
| style="text-align:right" | -145 |
| style="text-align:right" | -145 |
||
| Line 3,599: | Line 3,609: | ||
| style="text-align:right" | 175 |
| style="text-align:right" | 175 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Investment Income |
||
| style="text-align:right" | 1,319 |
| style="text-align:right" | 1,319 |
||
| style="text-align:right" | 2,525 |
| style="text-align:right" | 2,525 |
||
| Line 3,617: | Line 3,627: | ||
| style="text-align:right" | 456 |
| style="text-align:right" | 456 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Insurance Finance Expenses |
||
| style="text-align:right" | -783 |
| style="text-align:right" | -783 |
||
| style="text-align:right" | -1,551 |
| style="text-align:right" | -1,551 |
||
| Line 3,797: | Line 3,807: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w VFA |
||
| style="text-align:right" | 234,783 |
| style="text-align:right" | 234,783 |
||
| style="text-align:right" | 230,205 |
| style="text-align:right" | 230,205 |
||
| Line 3,815: | Line 3,825: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w Non VFA |
||
| style="text-align:right" | 94,677 |
| style="text-align:right" | 94,677 |
||
| style="text-align:right" | 114,803 |
| style="text-align:right" | 114,803 |
||
| Line 3,923: | Line 3,933: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w VFA Gross of reinsurance |
||
| style="text-align:right" | 264,013 |
| style="text-align:right" | 264,013 |
||
| style="text-align:right" | 273,094 |
| style="text-align:right" | 273,094 |
||
| Line 3,941: | Line 3,951: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w BBA Gross of reinsurance |
||
| style="text-align:right" | 50,097 |
| style="text-align:right" | 50,097 |
||
| style="text-align:right" | 51,845 |
| style="text-align:right" | 51,845 |
||
| Line 3,959: | Line 3,969: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w Reinsurance |
||
| style="text-align:right" | -18,768 |
| style="text-align:right" | -18,768 |
||
| style="text-align:right" | -18,690 |
| style="text-align:right" | -18,690 |
||
| Line 3,980: | Line 3,990: | ||
== L&H UE by Geography == |
== L&H UE by Geography == |
||
{{Indexing|Life & health underlying earnings build-up by geography|Life & Health underlying earnings, France, Europe, AXA XL, Asia, Africa & EME-LATAM, Transversal & Other|iycymgpuon|kind=table|order=11}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Life & health underlying earnings build-up by geography |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="4" style="text-align:center" | Total |
! colspan="4" style="text-align:center" | Total |
||
| Line 4,200: | Line 4,211: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Actual vs. Expected Cash Flows |
||
| style="text-align:right" | 9 |
| style="text-align:right" | 9 |
||
| style="text-align:right" | -15 |
| style="text-align:right" | -15 |
||
| Line 4,226: | Line 4,237: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Risk Adjustment Release |
||
| style="text-align:right" | 30 |
| style="text-align:right" | 30 |
||
| style="text-align:right" | 59 |
| style="text-align:right" | 59 |
||
| Line 4,252: | Line 4,263: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Changes in Onerous Contracts |
||
| style="text-align:right" | -32 |
| style="text-align:right" | -32 |
||
| style="text-align:right" | 6 |
| style="text-align:right" | 6 |
||
| Line 4,278: | Line 4,289: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Other Long-term |
||
| style="text-align:right" | -72 |
| style="text-align:right" | -72 |
||
| style="text-align:right" | -145 |
| style="text-align:right" | -145 |
||
| Line 4,356: | Line 4,367: | ||
| style="text-align:right" | 2 |
| style="text-align:right" | 2 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Investment Income |
||
| style="text-align:right" | 1,319 |
| style="text-align:right" | 1,319 |
||
| style="text-align:right" | 2,525 |
| style="text-align:right" | 2,525 |
||
| Line 4,382: | Line 4,393: | ||
| style="text-align:right" | 2 |
| style="text-align:right" | 2 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Insurance Finance Expenses |
||
| style="text-align:right" | -783 |
| style="text-align:right" | -783 |
||
| style="text-align:right" | -1,551 |
| style="text-align:right" | -1,551 |
||
| Line 4,746: | Line 4,757: | ||
| style="text-align:right" | '''0''' |
| style="text-align:right" | '''0''' |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w VFA Gross of reinsurance |
||
| style="text-align:right" | 264,013 |
| style="text-align:right" | 264,013 |
||
| style="text-align:right" | 273,094 |
| style="text-align:right" | 273,094 |
||
| Line 4,772: | Line 4,783: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w BBA Gross of reinsurance |
||
| style="text-align:right" | 50,097 |
| style="text-align:right" | 50,097 |
||
| style="text-align:right" | 51,845 |
| style="text-align:right" | 51,845 |
||
| Line 4,798: | Line 4,809: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w Reinsurance |
||
| style="text-align:right" | -18,768 |
| style="text-align:right" | -18,768 |
||
| style="text-align:right" | -18,690 |
| style="text-align:right" | -18,690 |
||
| Line 4,827: | Line 4,838: | ||
== Life UE by Geography == |
== Life UE by Geography == |
||
{{Indexing|Life underlying earnings build-up by geography|Life underlying earnings, France, Europe, AXA XL, Asia, Africa & EME-LATAM, Transversal & Other|iycymgpuon|kind=table|order=12}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Life underlying earnings build-up by geography |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="4" style="text-align:center" | Total |
! colspan="4" style="text-align:center" | Total |
||
| Line 5,047: | Line 5,059: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Actual vs. Expected Cash Flows |
||
| style="text-align:right" | -4 |
| style="text-align:right" | -4 |
||
| style="text-align:right" | -33 |
| style="text-align:right" | -33 |
||
| Line 5,073: | Line 5,085: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Risk Adjustment Release |
||
| style="text-align:right" | 25 |
| style="text-align:right" | 25 |
||
| style="text-align:right" | 51 |
| style="text-align:right" | 51 |
||
| Line 5,099: | Line 5,111: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Changes in Onerous Contracts |
||
| style="text-align:right" | -30 |
| style="text-align:right" | -30 |
||
| style="text-align:right" | 9 |
| style="text-align:right" | 9 |
||
| Line 5,125: | Line 5,137: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Other Long-term |
||
| style="text-align:right" | -63 |
| style="text-align:right" | -63 |
||
| style="text-align:right" | -124 |
| style="text-align:right" | -124 |
||
| Line 5,203: | Line 5,215: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Investment Income |
||
| style="text-align:right" | 1,159 |
| style="text-align:right" | 1,159 |
||
| style="text-align:right" | 2,209 |
| style="text-align:right" | 2,209 |
||
| Line 5,229: | Line 5,241: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Insurance Finance Expenses |
||
| style="text-align:right" | -705 |
| style="text-align:right" | -705 |
||
| style="text-align:right" | -1,410 |
| style="text-align:right" | -1,410 |
||
| Line 5,593: | Line 5,605: | ||
| style="text-align:right" | '''0''' |
| style="text-align:right" | '''0''' |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w VFA Gross of reinsurance |
||
| style="text-align:right" | 243,037 |
| style="text-align:right" | 243,037 |
||
| style="text-align:right" | 251,273 |
| style="text-align:right" | 251,273 |
||
| Line 5,619: | Line 5,631: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w BBA Gross of reinsurance |
||
| style="text-align:right" | 50,917 |
| style="text-align:right" | 50,917 |
||
| style="text-align:right" | 52,713 |
| style="text-align:right" | 52,713 |
||
| Line 5,645: | Line 5,657: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w Reinsurance |
||
| style="text-align:right" | -18,679 |
| style="text-align:right" | -18,679 |
||
| style="text-align:right" | -18,595 |
| style="text-align:right" | -18,595 |
||
| Line 5,674: | Line 5,686: | ||
== Health UE by Geography == |
== Health UE by Geography == |
||
{{Indexing|Health underlying earnings build-up by geography|Health underlying earnings, France, Europe, AXA XL, Asia, Africa & EME-LATAM, Transversal & Other|iycymgpuon|kind=table|order=13}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Health underlying earnings build-up by geography |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="4" style="text-align:center" | Total |
! colspan="4" style="text-align:center" | Total |
||
| Line 5,894: | Line 5,907: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Actual vs. Expected Cash Flows |
||
| style="text-align:right" | 13 |
| style="text-align:right" | 13 |
||
| style="text-align:right" | 18 |
| style="text-align:right" | 18 |
||
| Line 5,920: | Line 5,933: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Risk Adjustment Release |
||
| style="text-align:right" | 4 |
| style="text-align:right" | 4 |
||
| style="text-align:right" | 8 |
| style="text-align:right" | 8 |
||
| Line 5,946: | Line 5,959: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Changes in Onerous Contracts |
||
| style="text-align:right" | -1 |
| style="text-align:right" | -1 |
||
| style="text-align:right" | -2 |
| style="text-align:right" | -2 |
||
| Line 5,972: | Line 5,985: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Other Long-term |
||
| style="text-align:right" | -8 |
| style="text-align:right" | -8 |
||
| style="text-align:right" | -21 |
| style="text-align:right" | -21 |
||
| Line 6,050: | Line 6,063: | ||
| style="text-align:right" | 2 |
| style="text-align:right" | 2 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Investment Income |
||
| style="text-align:right" | 160 |
| style="text-align:right" | 160 |
||
| style="text-align:right" | 317 |
| style="text-align:right" | 317 |
||
| Line 6,076: | Line 6,089: | ||
| style="text-align:right" | 2 |
| style="text-align:right" | 2 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Insurance Finance Expenses |
||
| style="text-align:right" | -78 |
| style="text-align:right" | -78 |
||
| style="text-align:right" | -140 |
| style="text-align:right" | -140 |
||
| Line 6,440: | Line 6,453: | ||
| style="text-align:right" | '''0''' |
| style="text-align:right" | '''0''' |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w VFA Gross of reinsurance |
||
| style="text-align:right" | 20,977 |
| style="text-align:right" | 20,977 |
||
| style="text-align:right" | 21,821 |
| style="text-align:right" | 21,821 |
||
| Line 6,466: | Line 6,479: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w BBA Gross of reinsurance |
||
| style="text-align:right" | -821 |
| style="text-align:right" | -821 |
||
| style="text-align:right" | -868 |
| style="text-align:right" | -868 |
||
| Line 6,492: | Line 6,505: | ||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | o/w Reinsurance |
||
| style="text-align:right" | -90 |
| style="text-align:right" | -90 |
||
| style="text-align:right" | -95 |
| style="text-align:right" | -95 |
||
| Line 6,521: | Line 6,534: | ||
== Asset Management == |
== Asset Management == |
||
{{Indexing|Asset management opening AUM rollforward|Assets under management, net inflows, scope changes, market effect, FX|6jssxlwfy5|kind=table|order=14}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Asset management opening AUM rollforward |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="2" style="text-align:center" | 1H24 |
! colspan="2" style="text-align:center" | 1H24 |
||
| Line 6,601: | Line 6,615: | ||
| style="text-align:right" | '''341''' |
| style="text-align:right" | '''341''' |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Alternatives |
||
| style="text-align:right" | 227 |
| style="text-align:right" | 227 |
||
| style="text-align:right" | 86 |
| style="text-align:right" | 86 |
||
| Line 6,611: | Line 6,625: | ||
| style="text-align:right" | 95 |
| style="text-align:right" | 95 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Core & Other |
||
| style="text-align:right" | 532 |
| style="text-align:right" | 532 |
||
| style="text-align:right" | 254 |
| style="text-align:right" | 254 |
||
| Line 6,621: | Line 6,635: | ||
| style="text-align:right" | 246 |
| style="text-align:right" | 246 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Asian Joint Ventures |
||
| style="text-align:right" | 101 |
| style="text-align:right" | 101 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 6,651: | Line 6,665: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Management Fees |
||
| style="text-align:right" | 679 |
| style="text-align:right" | 679 |
||
| style="text-align:right" | 385 |
| style="text-align:right" | 385 |
||
| Line 6,661: | Line 6,675: | ||
| style="text-align:right" | 439 |
| style="text-align:right" | 439 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Performance Fees |
||
| style="text-align:right" | 18 |
| style="text-align:right" | 18 |
||
| style="text-align:right" | 8 |
| style="text-align:right" | 8 |
||
| Line 6,671: | Line 6,685: | ||
| style="text-align:right" | 9 |
| style="text-align:right" | 9 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Distribution Fees |
||
| style="text-align:right" | 205 |
| style="text-align:right" | 205 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 6,681: | Line 6,695: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Other |
||
| style="text-align:right" | 35 |
| style="text-align:right" | 35 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 6,701: | Line 6,715: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Distribution Fees Retroceded |
||
| style="text-align:right" | -205 |
| style="text-align:right" | -205 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 6,804: | Line 6,818: | ||
== Holdings == |
== Holdings == |
||
{{Indexing|Holdings underlying earnings build-up {{footnote{{!}}1{{=}}Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25.}}|Holdings underlying earnings, financial result, other revenues, other expenses, debt financing charges, tax, income from affiliates, minority interests|1smvf6a29l|kind=table|order=15}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Holdings underlying earnings build-up {{footnote|1=Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25.}} |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | 1H24 |
! class="col-s" style="text-align:right" | 1H24 |
||
| Line 6,869: | Line 6,884: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Holdings cash balance rollforward|Holdings cash balance, net cash remittance from subsidiaries, dividends, share buy-backs|75shp9ailk|kind=table|order=16}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Holdings cash balance rollforward |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | 1H24 |
! class="col-s" style="text-align:right" | 1H24 |
||
| Line 6,891: | Line 6,907: | ||
| style="text-align:right" | 7.5 |
| style="text-align:right" | 7.5 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Property & Casualty |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 4.0 |
| style="text-align:right" | 4.0 |
||
| Line 6,897: | Line 6,913: | ||
| style="text-align:right" | 5.1 |
| style="text-align:right" | 5.1 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Life & Health |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 3.6 |
| style="text-align:right" | 3.6 |
||
| Line 6,903: | Line 6,919: | ||
| style="text-align:right" | 2.5 |
| style="text-align:right" | 2.5 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Asset Management & Other |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | 0.1 |
| style="text-align:right" | 0.1 |
||
| Line 6,954: | Line 6,970: | ||
== Activity Indicators == |
== Activity Indicators == |
||
{{Indexing|Activity indicators by line of business build-up|Activity indicators, Property & Casualty, Life & Health, Employee Benefits, Life, Health, Asset Management, Bank|lht8rybaqk|kind=table|order=17}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Activity indicators by line of business build-up |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="8" style="text-align:center" | 1H24 |
! colspan="8" style="text-align:center" | 1H24 |
||
| Line 7,066: | Line 7,083: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | New Business Contractual Service Margin (NB CSM) |
||
| style="text-align:right" | 1,131 |
| style="text-align:right" | 1,131 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,100: | Line 7,117: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Other NBV {{footnote|1=Includes expected profits from short term Life & Health business, carried by Life entities, Pure Investment Contracts, NBV from Equity method entities as well as New Business Loss Components and Margin ceded to reinsurers.}} |
||
| style="text-align:right" | 456 |
| style="text-align:right" | 456 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,134: | Line 7,151: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Tax |
||
| style="text-align:right" | -381 |
| style="text-align:right" | -381 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 7,237: | Line 7,254: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Activity indicators by geography build-up|Activity indicators, Gross Written Premiums & Other Revenues, France, Europe, AXA XL, Asia, Africa & EME-LATAM, AXA IM, Transversal & Other|lht8rybaqk|kind=table|order=18}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Activity indicators by geography build-up |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! colspan="7" style="text-align:center" | 1H24 |
! colspan="7" style="text-align:center" | 1H24 |
||
| Line 7,337: | Line 7,355: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | New Business Contractual Service Margin (NB CSM) |
||
| style="text-align:right" | 1,131 |
| style="text-align:right" | 1,131 |
||
| style="text-align:right" | 203 |
| style="text-align:right" | 203 |
||
| Line 7,367: | Line 7,385: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Other NBV {{footnote|1=Includes expected profits from short term Life & Health business, carried by Life entities, Pure Investment Contracts, NBV from Equity method entities as well as New Business Loss Components and Margin ceded to reinsurers.}} |
||
| style="text-align:right" | 456 |
| style="text-align:right" | 456 |
||
| style="text-align:right" | 275 |
| style="text-align:right" | 275 |
||
| Line 7,397: | Line 7,415: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Tax |
||
| style="text-align:right" | -381 |
| style="text-align:right" | -381 |
||
| style="text-align:right" | -123 |
| style="text-align:right" | -123 |
||
| Line 7,490: | Line 7,508: | ||
== Balance Sheet == |
== Balance Sheet == |
||
{{Indexing|Assets build-up|Goodwill, other intangible assets, investments in real estate properties, financial investments, unit-linked assets, investments from insurance activities, investments from non-insurance activities, equity method investments, assets arising from insurance and reinsurance contracts held, present value of future cash flows, contractual service margin, risk adjustment|1f87rdfb5o|kind=table|order=19}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Assets build-up |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 7,538: | Line 7,557: | ||
| style="text-align:right" | 23.9 |
| style="text-align:right" | 23.9 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-2" style="text-align:left" | Present Value of Future Cash Flows |
||
| style="text-align:right" | 24.1 |
| style="text-align:right" | 24.1 |
||
| style="text-align:right" | 22.0 |
| style="text-align:right" | 22.0 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-2" style="text-align:left" | Contractual Service Margin |
||
| style="text-align:right" | 1.4 |
| style="text-align:right" | 1.4 |
||
| style="text-align:right" | 1.4 |
| style="text-align:right" | 1.4 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-2" style="text-align:left" | Risk Adjustment |
||
| style="text-align:right" | 0.5 |
| style="text-align:right" | 0.5 |
||
| style="text-align:right" | 0.5 |
| style="text-align:right" | 0.5 |
||
| Line 7,567: | Line 7,586: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Liabilities, non-controlling interests & shareholders' equity build-up|Shareholders' equity group share, non-controlling interests, financing debt, liabilities arising from insurance contracts and investment contracts with discretionary participation features, present value of future cash flows, contractual service margin, risk adjustment, other investment contract liabilities, liabilities arising from non-insurance activities, provisions for risks and charges|elseqv5tt7|kind=table|order=20}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Liabilities, non-controlling interests & shareholders' equity build-up |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 7,595: | Line 7,615: | ||
| style="text-align:right" | 470.4 |
| style="text-align:right" | 470.4 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-2" style="text-align:left" | Present Value of Future Cash Flows |
||
| style="text-align:right" | 438.4 |
| style="text-align:right" | 438.4 |
||
| style="text-align:right" | 432.6 |
| style="text-align:right" | 432.6 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-2" style="text-align:left" | Contractual Service Margin |
||
| style="text-align:right" | 35.3 |
| style="text-align:right" | 35.3 |
||
| style="text-align:right" | 34.7 |
| style="text-align:right" | 34.7 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-2" style="text-align:left" | Risk Adjustment |
||
| style="text-align:right" | 3.3 |
| style="text-align:right" | 3.3 |
||
| style="text-align:right" | 3.1 |
| style="text-align:right" | 3.1 |
||
| Line 7,638: | Line 7,658: | ||
== CSM rollforward == |
== CSM rollforward == |
||
{{Indexing|Contractual service margin rollforward, pre-tax and post-tax|Contractual service margin, new business CSM, underlying return on inforce, CSM release, economic variance, operating variance, other, P&C, Life, Health|cqvs0n2z2e|kind=table|order=21}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Contractual service margin rollforward, pre-tax and post-tax |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | FY23 Restated {{footnote|1=Following the termination of the sale of a closed life and pensions portfolio at AXA Germany in 2024. It was classified as held for sale in 2023.}} |
! class="col-s" style="text-align:right" | FY23 Restated {{footnote|1=Following the termination of the sale of a closed life and pensions portfolio at AXA Germany in 2024. It was classified as held for sale in 2023.}} |
||
| Line 7,662: | Line 7,683: | ||
| style="text-align:right" | '''33,853''' |
| style="text-align:right" | '''33,853''' |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-2" style="text-align:left" | P&C |
||
| style="text-align:right" | 206 |
| style="text-align:right" | 206 |
||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
| Line 7,672: | Line 7,693: | ||
| style="text-align:right" | 282 |
| style="text-align:right" | 282 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-2" style="text-align:left" | Life |
||
| style="text-align:right" | 26,200 |
| style="text-align:right" | 26,200 |
||
| style="text-align:right" | 1,770 |
| style="text-align:right" | 1,770 |
||
| Line 7,682: | Line 7,703: | ||
| style="text-align:right" | 25,826 |
| style="text-align:right" | 25,826 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-2" style="text-align:left" | Health |
||
| style="text-align:right" | 7,782 |
| style="text-align:right" | 7,782 |
||
| style="text-align:right" | 400 |
| style="text-align:right" | 400 |
||
| Line 7,703: | Line 7,724: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Contractual service margin rollforward, pre-tax and post-tax|Contractual service margin, new business CSM, underlying return on inforce, CSM release, economic variance, operating variance, other, P&C, Life, Health|cqvs0n2z2e|kind=table|order=22}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Contractual service margin rollforward, pre-tax and post-tax |
|||
! style="text-align:left" | EUR million |
! style="text-align:left" | EUR million |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 7,727: | Line 7,749: | ||
| style="text-align:right" | '''33,253''' |
| style="text-align:right" | '''33,253''' |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-2" style="text-align:left" | P&C |
||
| style="text-align:right" | 282 |
| style="text-align:right" | 282 |
||
| style="text-align:right" | 0 |
| style="text-align:right" | 0 |
||
| Line 7,737: | Line 7,759: | ||
| style="text-align:right" | 261 |
| style="text-align:right" | 261 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-2" style="text-align:left" | Life |
||
| style="text-align:right" | 25,826 |
| style="text-align:right" | 25,826 |
||
| style="text-align:right" | 1,822 |
| style="text-align:right" | 1,822 |
||
| Line 7,747: | Line 7,769: | ||
| style="text-align:right" | 25,442 |
| style="text-align:right" | 25,442 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-2" style="text-align:left" | Health |
||
| style="text-align:right" | 7,744 |
| style="text-align:right" | 7,744 |
||
| style="text-align:right" | 377 |
| style="text-align:right" | 377 |
||
| Line 7,770: | Line 7,792: | ||
== Invested Assets == |
== Invested Assets == |
||
{{Indexing|General account invested assets breakdown by asset class and rating|General account invested assets, fixed income, equities, real estate, alternative investments, cash, other invested assets|966xer0dpm|kind=table|order=23}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ General account invested assets breakdown by asset class and rating |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! style="text-align:center" | Fair value |
! style="text-align:center" | Fair value |
||
| Line 7,820: | Line 7,843: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Government Bonds |
||
| style="text-align:right" | 167 |
| style="text-align:right" | 167 |
||
| style="text-align:right" | 37% |
| style="text-align:right" | 37% |
||
| Line 7,833: | Line 7,856: | ||
| style="text-align:right" | 2% |
| style="text-align:right" | 2% |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Corporate Bonds and Loans |
||
| style="text-align:right" | 121 |
| style="text-align:right" | 121 |
||
| style="text-align:right" | 27% |
| style="text-align:right" | 27% |
||
| Line 7,846: | Line 7,869: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Other Fixed Income |
||
| style="text-align:right" | 56 |
| style="text-align:right" | 56 |
||
| style="text-align:right" | 13% |
| style="text-align:right" | 13% |
||
| Line 7,859: | Line 7,882: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-2" style="text-align:left" | Asset Backed Securities {{footnote|1=Includes 91% of CLOs.}} |
||
| style="text-align:right" | 25 |
| style="text-align:right" | 25 |
||
| style="text-align:right" | 6% |
| style="text-align:right" | 6% |
||
| Line 7,872: | Line 7,895: | ||
| style="text-align:right" | 4% |
| style="text-align:right" | 4% |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-2" style="text-align:left" | Mortgage Loans {{footnote|1=Residential loans (Euro 16 billion), Agency Pools (Euro 8 billion), and Commercial & agricultural loans (Euro 7 billion).}} |
||
| style="text-align:right" | 31 |
| style="text-align:right" | 31 |
||
| style="text-align:right" | 7% |
| style="text-align:right" | 7% |
||
| Line 7,966: | Line 7,989: | ||
== Supplementary Info on Asset == |
== Supplementary Info on Asset == |
||
{{Indexing|Government bonds breakdown by geographical exposure|Government bonds, geographical exposure, Belgium, France, Germany, Italy, Japan, Netherlands, Spain, Switzerland, United States, Other EU countries, Supranational, Rest of the World|utnmaoxh50|kind=table|order=24}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Government bonds breakdown by geographical exposure |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | Fair Value |
! class="col-s" style="text-align:right" | Fair Value |
||
| Line 8,001: | Line 8,025: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Corporate bonds and loans breakdown by industry|Corporate bonds, loans, industry breakdown, Basic Materials, Communications, Consumer Cyclical, Consumer Non-Cyclical, Covered and Senior Secured Bonds, Energy, Financials, Industrial, Technology, Utilities|966xer0dpm|kind=table|order=25}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Corporate bonds and loans breakdown by industry |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | Fair Value |
! class="col-s" style="text-align:right" | Fair Value |
||
| Line 8,034: | Line 8,059: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Corporate bonds and loans exposure to financials by type {{footnote{{!}}1{{=}}Includes REITS corporate bonds (Euro 3 billion).}}|Corporate bonds, loans, exposure to financials, Banks, Non-Banks, Senior Unsecured Bonds, Subordinated Bonds|966xer0dpm|kind=table|order=26}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Corporate bonds and loans exposure to financials by type {{footnote|1=Includes REITS corporate bonds (Euro 3 billion).}} |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | Total |
! class="col-s" style="text-align:right" | Total |
||
| Line 8,064: | Line 8,090: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Listed equities breakdown by asset domiciliation|Listed equities, asset domiciliation, Belgium, France, Germany, Japan, Netherlands, Switzerland, United States, Other EU countries, Rest of the World|966xer0dpm|kind=table|order=27}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Listed equities breakdown by asset domiciliation |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | Fair Value |
! class="col-s" style="text-align:right" | Fair Value |
||
| Line 8,093: | Line 8,120: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Listed equities breakdown by industry {{footnote{{!}}1{{=}}Including hedges.}}|Listed equities, industry breakdown, Basic Materials, Communications, Consumer Cyclical, Consumer Non-Cyclical, Diversified, Energy, Financials, Funds, Industrial, Technology, Utilities|966xer0dpm|kind=table|order=28}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Listed equities breakdown by industry {{footnote|1=Including hedges.}} |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | Fair Value |
! class="col-s" style="text-align:right" | Fair Value |
||
| Line 8,128: | Line 8,156: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Real estate breakdown by geographical exposure|Real estate, geographical exposure, Belgium, France, Germany, Italy, Japan, Spain, Switzerland, United Kingdom, United States, Other EU countries, Rest of the World|t30sdfi0wn|kind=table|order=29}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Real estate breakdown by geographical exposure |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | Fair Value |
! class="col-s" style="text-align:right" | Fair Value |
||
| Line 8,161: | Line 8,190: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Real estate breakdown by type|Real estate, type breakdown, Office, Residential, Industrial-Logistic, Retail|t30sdfi0wn|kind=table|order=30}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Real estate breakdown by type |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | Fair Value |
! class="col-s" style="text-align:right" | Fair Value |
||
| Line 8,182: | Line 8,212: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Private equities breakdown by asset domiciliation {{footnote{{!}}1{{=}}Excluding Non-listed Equity.}}|Private equities, asset domiciliation, Europe, Japan, United States|gp3o3dfk95|kind=table|order=31}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Private equities breakdown by asset domiciliation {{footnote|1=Excluding Non-listed Equity.}} |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | Fair Value |
! class="col-s" style="text-align:right" | Fair Value |
||
| Line 8,201: | Line 8,232: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Mortgage loans breakdown by type|Mortgage loans, type breakdown, Residential, Commercial|966xer0dpm|kind=table|order=32}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Mortgage loans breakdown by type |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | Fair Value |
! class="col-s" style="text-align:right" | Fair Value |
||
| Line 8,218: | Line 8,250: | ||
== Shareholders Equity == |
== Shareholders Equity == |
||
{{Indexing|Change in group share consolidated shareholders' equity rollforward|Shareholders' equity rollforward, Paid-in Capital, Treasury Shares, Other Comprehensive Income, Currency Fluctuations, Undated Subordinated Debt, Realized Gains, Dividends, Net Income|z6dk9e62ik|kind=table|order=33}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Change in group share consolidated shareholders' equity rollforward |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
| Line 8,240: | Line 8,273: | ||
| style="text-align:right" | 1.3 |
| style="text-align:right" | 1.3 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Other Comprehensive Income Related to Invested Assets |
||
| style="text-align:right" | -4.2 |
| style="text-align:right" | -4.2 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Other Comprehensive Income Related to (re) Insurance Contracts |
||
| style="text-align:right" | 5.4 |
| style="text-align:right" | 5.4 |
||
|- |
|- |
||
| Line 8,268: | Line 8,301: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Group share consolidated shareholders' equity build-up|Shareholders' equity build-up, Paid-in Capital, Treasury Shares, Other Comprehensive Income, Translation Reserves, Undated Subordinated Debt, Retained Earnings|0lk0pqg9zh|kind=table|order=34}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Group share consolidated shareholders' equity build-up |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 8,292: | Line 8,326: | ||
| style="text-align:right" | -6.8 |
| style="text-align:right" | -6.8 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Other Comprehensive Income Related to Invested Assets |
||
| style="text-align:right" | -13.1 |
| style="text-align:right" | -13.1 |
||
| style="text-align:right" | -17.3 |
| style="text-align:right" | -17.3 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Other Comprehensive Income Related to (re) Insurance Contracts |
||
| style="text-align:right" | 5.0 |
| style="text-align:right" | 5.0 |
||
| style="text-align:right" | 10.5 |
| style="text-align:right" | 10.5 |
||
| Line 8,317: | Line 8,351: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Book value per share and shareholders' equity plus CSM per share|Book value per share, shareholders' equity plus CSM per share|0lk0pqg9zh|c9uq82u1iy|kind=table|order=35}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Book value per share and shareholders' equity plus CSM per share |
|||
! style="text-align:left" | EUR |
! style="text-align:left" | EUR |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 8,334: | Line 8,369: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Unrealized gains and losses on invested assets net of tax build-up|Unrealized gains and losses on invested assets, Government Bonds, Corporate Bonds, Cash Flow hedges, Equities, Real Estate|j8uunnd14x|kind=table|order=36}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Unrealized gains and losses on invested assets net of tax build-up |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 8,385: | Line 8,421: | ||
== RoE & Gearing == |
== RoE & Gearing == |
||
{{Indexing|Return on equity by type|Return on equity, Net Income ROE, Underlying ROE, Net Income, Average Adjusted Shareholders' Equity, Underlying Earnings|0lk0pqg9zh|kind=table|order=37}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Return on equity by type |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 8,425: | Line 8,462: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Debt gearing build-up|Debt gearing build-up, Financing Debt, Dated Subordinated Debt, Total Gross Debt, Undated Deeply Subordinated Notes, Deeply Subordinated Notes, Shareholders' Equity, Contractual Service Margin|b3bc9gy5x7|kind=table|order=38}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Debt gearing build-up |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 8,437: | Line 8,475: | ||
| style="text-align:right" | 3.2 |
| style="text-align:right" | 3.2 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Financing Debt Instrument Issued |
||
| style="text-align:right" | 3.2 |
| style="text-align:right" | 3.2 |
||
| style="text-align:right" | 3.2 |
| style="text-align:right" | 3.2 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Financing Debt Owed to Credit Institutions |
||
| style="text-align:right" | 0.0 |
| style="text-align:right" | 0.0 |
||
| style="text-align:right" | 0.0 |
| style="text-align:right" | 0.0 |
||
| Line 8,488: | Line 8,526: | ||
== Information on Solvency II == |
== Information on Solvency II == |
||
{{Indexing|Solvency II rollforward|Solvency II rollforward, Eligible Own Fund (EOF), Solvency Capital Requirement (SCR), Solvency II Ratio, Regulatory & model changes, Normalized Capital Generation, Operating variance, Economic variance, Dividend & share buy-backs, Debt, M&A, In-force and Other|2vtd347257|kind=table|order=39}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Solvency II rollforward |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 8,537: | Line 8,576: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Eligible own fund tiering by sector|Eligible own fund tiering, Unrestricted Tier 1, Restricted Tier 1, Tier 2, Tier 3, Insurance Sector, Other Financial Sectors|mvr3j6qvh9|kind=table|order=40}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Eligible own fund tiering by sector |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | Total |
! class="col-s" style="text-align:right" | Total |
||
| Line 8,562: | Line 8,602: | ||
| style="text-align:right" | 0.4 |
| style="text-align:right" | 0.4 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Ancillary |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 8,569: | Line 8,609: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Subject to Transitional Measures {{footnote|1=Transitional measures on basic own funds applied on subordinated debts eligible under Solvency I regulation. These subordinated debts were also eligible under Solvency II until December 31, 2025. They are no longer eligible since January 1, 2026.}} |
||
| style="text-align:right" | 2.4 |
| style="text-align:right" | 2.4 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 8,597: | Line 8,637: | ||
| style="text-align:right" | 0.8 |
| style="text-align:right" | 0.8 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Ancillary |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 8,604: | Line 8,644: | ||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-1" style="text-align:left" | Subject to Transitional Measures {{footnote|1=Transitional measures on basic own funds applied on subordinated debts eligible under Solvency I regulation. These subordinated debts were also eligible under Solvency II until December 31, 2025. They are no longer eligible since January 1, 2026.}} |
||
| style="text-align:right" | 4.5 |
| style="text-align:right" | 4.5 |
||
| style="text-align:right" | — |
| style="text-align:right" | — |
||
| Line 8,619: | Line 8,659: | ||
|} |
|} |
||
</div> |
</div> |
||
{{Indexing|Solvency II key sensitivities|Solvency II sensitivities, Interest Rate, Corporate Spread, Euro Government Spreads, Credit Migration, Listed Equities, Private and Infrastructure Equity, Inflation swap curve|vxha3w1l2k|kind=table|order=41}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Solvency II key sensitivities |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | FY24 |
! class="col-s" style="text-align:right" | FY24 |
||
| Line 8,670: | Line 8,711: | ||
== IFRS17 SHE to Group EOF == |
== IFRS17 SHE to Group EOF == |
||
{{Indexing|Reconciliation IFRS 17/9 shareholders' equity to Solvency II eligible own funds|Reconciliation IFRS 17/9 shareholders' equity to Solvency II eligible own funds, IFRS SHAREHOLDERS' EQUITY, Contractual Service Margin, Net URCG, Undated Subordinated Debts, Intangibles, IFRS TANGIBLE NET ASSET VALUE, Foreseeable dividends and distribution, Technical provision adjustments, Other adjustments, UNRESTRICTED TIER 1, Restricted Tier 1, Tier 2, Tier 3, GROUP ELIGIBLE OWN FUNDS|vmox6ji65o|kind=table|order=42}} |
|||
<div style="overflow-x:auto"> |
<div style="overflow-x:auto"> |
||
{| class="wikitable fintable" |
{| class="wikitable fintable" |
||
|+ Reconciliation IFRS 17/9 shareholders' equity to Solvency II eligible own funds |
|||
! style="text-align:left" | EUR billion |
! style="text-align:left" | EUR billion |
||
! class="col-s" style="text-align:right" | FY25 |
! class="col-s" style="text-align:right" | FY25 |
||
| Line 8,695: | Line 8,737: | ||
| style="text-align:right" | -21.3 |
| style="text-align:right" | -21.3 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-4" style="text-align:left" | Goodwill |
||
| style="text-align:right" | -17.8 |
| style="text-align:right" | -17.8 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-4" style="text-align:left" | others |
||
| style="text-align:right" | -3.5 |
| style="text-align:right" | -3.5 |
||
|- |
|- |
||
| Line 8,710: | Line 8,752: | ||
| style="text-align:right" | -9.6 |
| style="text-align:right" | -9.6 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-4" style="text-align:left" | Risk Margin vs Risk Adjustment |
||
| style="text-align:right" | -6.4 |
| style="text-align:right" | -6.4 |
||
|- |
|- |
||
| style="text-align:left |
| class="wt-indent-4" style="text-align:left" | BEL adjustment |
||
| style="text-align:right" | -3.2 |
| style="text-align:right" | -3.2 |
||
|- |
|- |
||
Latest revision as of 11:15, 5 July 2026
| Document info | |
|---|---|
| Organization | AXA |
| Year | 2025 |
| Period | FY |
| Period label | FY25 |
| Document category | Financial supplement |
| Document name | AXA FY 2025 Financial Supplement (Excel) |
| Publication date | 2026-02-26 |
| Language | English |
| Source | Original URL |
| Archive file | .md file |
This article presents AXA's FY 2025 financial supplement — the detailed data tables behind the period's results.
Market Data
Exchange rate by currency
| — | 1H24 | FY24 | 1H25 | FY25 | Average 1H24 | Average FY24 | Average 1H25 | Average FY25 |
|---|---|---|---|---|---|---|---|---|
| USD | 1.07 | 1.04 | 1.17 | 1.17 | 1.08 | 1.08 | 1.09 | 1.13 |
| JPY | 172 | 163 | 170 | 184 | 165 | 164 | 162 | 169 |
| GBP | 0.85 | 0.83 | 0.86 | 0.87 | 0.85 | 0.85 | 0.84 | 0.86 |
| CHF | 0.96 | 0.94 | 0.93 | 0.93 | 0.96 | 0.95 | 0.94 | 0.94 |
| HKD | 8.37 | 8.04 | 9.21 | 9.14 | 8.45 | 8.44 | 8.53 | 8.82 |
Discount rate 5Y by currency
| % | Average 1H24 | Average FY24 | Average 1H25 | Average FY25 |
|---|---|---|---|---|
| EUR | 2.79% | 2.84% | 2.57% | 2.59% |
| USD | 4.35% | 4.41% | 4.40% | 4.23% |
| JPY | 0.22% | 0.42% | 0.89% | 1.01% |
| GBP | 4.00% | 4.25% | 4.38% | 4.31% |
| CHF | 1.05% | 0.82% | 0.18% | 0.16% |
| HKD | 3.75% | 3.67% | 3.45% | 3.18% |
Discount rate 10Y by currency
| % | Closing 1H24 | Closing FY24 | Closing 1H25 | Closing FY25 |
|---|---|---|---|---|
| EUR | 3.06% | 2.71% | 2.91% | 3.17% |
| USD | 4.54% | 4.66% | 4.43% | 4.45% |
| JPY | 1.04% | 1.07% | 1.44% | 2.08% |
| GBP | 4.27% | 4.48% | 4.56% | 4.55% |
| CHF | 0.98% | 0.38% | 0.53% | 0.67% |
| HKD | 3.79% | 3.91% | 3.02% | 3.21% |
UE by LOB and Net Income
Group underlying earnings and net income build-up by line of business
| EUR million | Group | Property & Casualty | Life & Health | Asset Management (footnote: AXA IM FY contribution presented in this document corresponds to its effective contribution to the Group’s results over the period of time when it was consolidated, i.e. until 1st July 2025.) | Holdings (footnote: Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25.) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 35,273 | 72,104 | 37,209 | 75,071 | 27,294 | 55,898 | 28,697 | 57,656 | 7,979 | 16,207 | 8,512 | 17,416 | — | — | — | — | — | — | — | — |
| Combined Ratio | — | — | — | — | 90.2% | 91.0% | 90.0% | 90.6% | 97.6% | 97.4% | 97.1% | 97.2% | — | — | — | — | — | — | — | — |
| Technical Margin | 2,877 | 5,421 | 3,107 | 5,888 | 2,682 | 5,006 | 2,859 | 5,409 | 195 | 415 | 248 | 479 | — | — | — | — | — | — | — | — |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | 1,395 | 2,775 | 1,428 | 2,954 | — | — | — | — | 1,395 | 2,775 | 1,428 | 2,954 | — | — | — | — | — | — | — | — |
| Technical Experience | -64 | -95 | -30 | -150 | — | — | — | — | -64 | -95 | -30 | -150 | — | — | — | — | — | — | — | — |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 2,064 | 3,971 | 2,148 | 4,013 | 1,324 | 2,559 | 1,343 | 2,631 | 536 | 975 | 563 | 946 | 24 | 35 | 14 | 14 | 181 | 402 | 228 | 422 |
| Other Revenues | 1,459 | 3,054 | 1,625 | 2,167 | — | — | — | — | — | — | — | — | 937 | 2,004 | 1,018 | 1,018 | 522 | 1,050 | 607 | 1,149 |
| Other Expenses | -1,624 | -3,479 | -1,868 | -2,900 | — | — | — | — | — | — | — | — | -698 | -1,493 | -793 | -793 | -925 | -1,986 | -1,075 | -2,107 |
| Debt Financing Charges | -471 | -948 | -452 | -928 | — | — | — | — | — | — | — | — | — | — | — | — | -471 | -948 | -452 | -928 |
| Underlying Earnings Before Tax | 5,638 | 10,700 | 5,958 | 11,044 | 4,006 | 7,565 | 4,202 | 8,040 | 2,061 | 4,070 | 2,209 | 4,229 | 263 | 546 | 239 | 239 | -693 | -1,482 | -692 | -1,464 |
| Tax | -1,427 | -2,662 | -1,503 | -2,644 | -1,046 | -1,952 | -1,074 | -2,060 | -412 | -874 | -462 | -800 | -69 | -160 | -68 | -68 | 100 | 324 | 101 | 284 |
| Income from Affiliates & Other | 122 | 218 | 111 | 168 | 2 | 3 | 1 | 3 | 103 | 186 | 101 | 157 | 16 | 29 | 8 | 8 | 0 | 0 | 0 | 0 |
| Minority Interests | -89 | -179 | -101 | -199 | -56 | -106 | -63 | -111 | -27 | -60 | -34 | -85 | -6 | -13 | -4 | -4 | 0 | 0 | 0 | 0 |
| Underlying Earnings Group Share | 4,244 | 8,078 | 4,465 | 8,368 | 2,908 | 5,510 | 3,067 | 5,872 | 1,725 | 3,323 | 1,814 | 3,501 | 204 | 402 | 175 | 175 | -592 | -1,157 | -591 | -1,180 |
| Underlying Earnings Growth Rate (constant FX) | 4% | 7% | 6% | 6% | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying ROE | 16.6% | 15.2% | 17.5% | 16.0% | — | 16.2% | — | 17.3% | — | 13.6% | — | 14.4% | — | 26.0% | — | n.a. | — | — | — | — |
| Net Realized Capital Gains & Losses | 93 | 195 | 66 | 138 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Change in Fair Value of Assets & Derivatives | -43 | 83 | -467 | -813 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Amortization of customer intangibles | -50 | -131 | -48 | -86 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Integration and Restructuring Costs | -78 | -240 | -63 | -197 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Exceptional Items | -147 | -99 | -30 | 2,386 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income Group Share | 4,020 | 7,886 | 3,922 | 9,797 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Deeply Subordinated and Undated Subordinated Debt Charges | -106 | -201 | -86 | -174 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings for EPS calculation | 4,138 | 7,877 | 4,379 | 8,195 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net Income for EPS calculation | 3,914 | 7,685 | 3,836 | 9,623 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
UE by Geography
Underlying earnings build-up by geography
| EUR million | Group | France | Europe | AXA XL | Asia, Africa & EME-LATAM | AXA IM (footnote: AXA IM FY contribution presented in this document corresponds to its effective contribution to the Group’s results over the period of time when it was consolidated, i.e. until 1st July 2025.) | Transversal & Other | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 35,273 | 72,104 | 37,209 | 75,071 | 9,046 | 18,698 | 9,567 | 19,555 | 11,839 | 24,005 | 12,661 | 25,724 | 9,022 | 18,530 | 9,428 | 18,699 | 4,312 | 8,750 | 4,478 | 8,986 | — | — | — | — | 1,053 | 2,122 | 1,075 | 2,107 |
| Combined Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Technical Margin | 2,877 | 5,421 | 3,107 | 5,888 | 692 | 1,470 | 658 | 1,485 | 998 | 1,957 | 1,176 | 2,357 | 1,111 | 1,820 | 1,074 | 1,928 | 70 | 81 | 150 | 9 | — | — | — | — | 6 | 93 | 49 | 109 |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | 1,395 | 2,775 | 1,428 | 2,954 | 407 | 823 | 419 | 895 | 468 | 920 | 471 | 984 | 4 | 3 | 0 | 1 | 516 | 1,029 | 538 | 1,074 | — | — | — | — | 0 | 0 | 0 | 0 |
| Technical Experience | -64 | -95 | -30 | -150 | -40 | -96 | -37 | -81 | -11 | -8 | 8 | -70 | 3 | 2 | 0 | -5 | -17 | 7 | -1 | 6 | — | — | — | — | 0 | 0 | 0 | 0 |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 2,064 | 3,971 | 2,148 | 4,013 | 350 | 613 | 380 | 667 | 784 | 1,486 | 765 | 1,398 | 283 | 616 | 308 | 651 | 382 | 741 | 425 | 782 | 24 | 35 | 14 | 14 | 241 | 480 | 255 | 502 |
| Other Revenues | 1,459 | 3,054 | 1,625 | 2,167 | 53 | 108 | 44 | 91 | -18 | -32 | -8 | -12 | 0 | 0 | 0 | 0 | 0 | 0 | -2 | -3 | 937 | 2,004 | 1,018 | 1,018 | 488 | 974 | 573 | 1,073 |
| Other Expenses | -1,624 | -3,479 | -1,868 | -2,900 | -83 | -180 | -79 | -168 | -10 | -25 | -6 | -3 | 0 | 0 | 0 | 0 | -9 | -20 | -14 | -26 | -698 | -1,493 | -793 | -793 | -823 | -1,761 | -976 | -1,910 |
| Debt Financing Charges | -471 | -948 | -452 | -928 | 0 | 0 | 0 | 0 | -1 | -2 | -1 | -2 | -16 | -33 | -16 | -32 | -7 | -12 | -4 | -6 | — | — | — | — | -447 | -902 | -431 | -887 |
| Underlying Earnings Before Tax | 5,638 | 10,700 | 5,958 | 11,044 | 1,380 | 2,738 | 1,384 | 2,888 | 2,210 | 4,297 | 2,406 | 4,651 | 1,385 | 2,409 | 1,366 | 2,543 | 935 | 1,826 | 1,093 | 1,835 | 263 | 546 | 239 | 239 | -535 | -1,116 | -530 | -1,113 |
| Tax | -1,427 | -2,662 | -1,503 | -2,644 | -350 | -676 | -308 | -665 | -536 | -1,004 | -568 | -1,039 | -355 | -588 | -342 | -650 | -205 | -443 | -294 | -434 | -69 | -160 | -68 | -68 | 88 | 209 | 76 | 212 |
| Income from Affiliates & Other | 122 | 218 | 111 | 168 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 102 | 181 | 103 | 160 | 16 | 29 | 8 | 8 | 0 | 0 | 0 | 0 |
| Minority Interests | -89 | -179 | -101 | -199 | 0 | 0 | 0 | 0 | -48 | -105 | -56 | -126 | 0 | 0 | 0 | 0 | -34 | -60 | -39 | -68 | -6 | -13 | -4 | -4 | 0 | 0 | -1 | -2 |
| Underlying Earnings Group share | 4,244 | 8,078 | 4,465 | 8,368 | 1,034 | 2,071 | 1,076 | 2,224 | 1,626 | 3,187 | 1,782 | 3,486 | 1,030 | 1,820 | 1,024 | 1,893 | 798 | 1,504 | 862 | 1,493 | 204 | 402 | 175 | 175 | -447 | -907 | -455 | -903 |
Underlying earnings by line of business and geography
| EUR million | Group | France | Europe | AXA XL | Asia, Africa & EME-LATAM | AXA IM (footnote: AXA IM FY contribution presented in this document corresponds to its effective contribution to the Group’s results over the period of time when it was consolidated, i.e. until 1st July 2025.) | Transversal & Other | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Underlying Earnings by Line of Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Property & Casualty | 2,908 | 5,510 | 3,067 | 5,872 | 539 | 1,161 | 574 | 1,237 | 1,073 | 2,029 | 1,152 | 2,216 | 1,032 | 1,828 | 1,032 | 1,913 | 194 | 334 | 233 | 355 | — | — | — | — | 70 | 158 | 75 | 151 |
| Life & Health | 1,725 | 3,323 | 1,814 | 3,501 | 519 | 964 | 524 | 1,039 | 559 | 1,104 | 616 | 1,264 | 14 | 25 | 8 | 12 | 627 | 1,211 | 653 | 1,165 | — | — | — | — | 7 | 19 | 14 | 22 |
| Asset Management | 204 | 402 | 175 | 175 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 204 | 402 | 175 | 175 | — | — | — | — |
| Holdings (footnote: Includes Bank with Underlying Earnings Group Share of Euro -24 million as of 1H24, -55 million as of FY24, -24 million as of 1H25 and -54 million as of FY25.) | -592 | -1,157 | -591 | -1,180 | -24 | -54 | -23 | -52 | -6 | 54 | 14 | 6 | -16 | -33 | -16 | -32 | -23 | -41 | -24 | -26 | — | — | — | — | -524 | -1,083 | -543 | -1,076 |
| Outstanding Shares Excluding Treasury Shares (footnote: Under IFRS, Treasury shares are not considered as outstanding shares. Treasury shares amounted to 35 million shares as of FY25 and 39 million shares as of FY24.) | Weighted Average Number | |||
|---|---|---|---|---|
| — | FY24 | FY25 | FY24 | FY25 |
| Basic Number of Shares | — | — | — | — |
| As of Beginning of Period | 2,226.2 | 2,175.4 | 2,226.2 | 2,175.4 |
| Increase of Capital Dedicated to Employees | 12.9 | 12.7 | 0.9 | 1.0 |
| Exercice of Stock-options | 2.6 | 1.1 | 1.4 | 0.6 |
| Other Movement of Treasury Shares | 4.6 | 4.2 | 17.5 | 6.3 |
| Capital Increase / (Decrease) | -70.9 | -138.0 | -55.2 | -64.9 |
| As at End of Period | 2,175.4 | 2,055.4 | — | — |
| During the Period | — | — | 2,190.8 | 2,118.3 |
| Fully Diluted Number of Shares | — | — | — | — |
| Stock Options | — | — | 0.8 | 0.6 |
| Performance Shares | — | — | 5.6 | 5.1 |
| During the Period (A) | — | — | 2,197.1 | 2,124.0 |
| Earnings Group Share: | — | — | — | — |
| Net Income | — | — | 7,886 | 9,797 |
| Underlying Earnings | — | — | 8,078 | 8,368 |
| Impact of undated and deeply subordinated debts: | — | — | — | — |
| Undated and deeply subordinated debt charges | — | — | -201 | -174 |
| Earnings for EPS Calculation: | — | — | — | — |
| Net Income for EPS Calculation (B) | — | — | 7,685 | 9,623 |
| Underlying Earnings for EPS Calculation (C) | — | — | 7,877 | 8,195 |
| Fully Diluted Euro per Share (EPS) | — | — | — | — |
| EPS (B/A) | — | — | 3.50 | 4.53 |
| Underlying EPS (C/A) | — | — | 3.59 | 3.86 |
P&C UE by Sub LOB
Property & casualty underlying earnings build-up by line of business
| EUR million | Total | Commercial lines | Personal lines | AXA XL Reinsurance | Intercompany eliminations | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 27,294 | 55,898 | 28,697 | 57,656 | 18,657 | 38,019 | 19,575 | 39,090 | 9,144 | 18,705 | 9,513 | 19,276 | 1,155 | 2,394 | 1,299 | 2,493 | -1,662 | -3,220 | -1,689 | -3,203 |
| Current Accident Year Loss Ratio | 67.0% | 67.7% | 66.7% | 66.9% | 68.1% | 68.8% | 68.0% | 68.0% | 69.8% | 70.0% | 68.8% | 69.1% | 69.7% | 70.6% | 70.8% | 71.9% | — | — | — | — |
| Undiscounted Current Accident Year Loss Ratio (excl. Nat Cats) | 67.4% | 67.4% | 67.0% | 67.0% | 69.2% | 69.4% | 69.3% | 68.8% | 68.8% | 68.5% | 67.5% | 67.9% | 68.0% | 67.9% | 69.4% | 71.5% | — | — | — | — |
| Undiscounted Current Accident Year Nat Cats | 3.6% | 3.8% | 3.5% | 3.4% | 2.7% | 2.9% | 2.7% | 2.6% | 4.0% | 4.1% | 3.8% | 3.6% | 10.6% | 10.4% | 9.2% | 8.7% | — | — | — | — |
| Current Accident Year Discounting | -3.9% | -3.6% | -3.9% | -3.5% | -3.7% | -3.5% | -3.9% | -3.5% | -3.0% | -2.6% | -2.6% | -2.4% | -8.8% | -7.7% | -7.8% | -8.3% | — | — | — | — |
| Prior Year Reserve Development Ratio | -1.5% | -1.6% | -1.1% | -1.1% | -1.1% | -1.2% | -1.3% | -0.8% | -2.3% | -1.8% | -0.6% | -1.6% | -1.1% | -0.8% | -0.3% | 0.0% | — | — | — | — |
| Expense Ratio | 24.7% | 25.0% | 24.5% | 24.8% | 23.1% | 23.6% | 23.2% | 23.5% | 25.5% | 25.7% | 25.1% | 25.2% | 10.0% | 9.9% | 9.1% | 9.4% | — | — | — | — |
| Combined Ratio | 90.2% | 91.0% | 90.0% | 90.6% | 90.1% | 91.1% | 89.9% | 90.7% | 92.9% | 93.9% | 93.3% | 92.8% | 78.7% | 79.7% | 79.6% | 81.4% | — | — | — | — |
| Technical Margin | 2,682 | 5,006 | 2,859 | 5,409 | 1,850 | 3,372 | 1,968 | 3,616 | 645 | 1,136 | 638 | 1,392 | 246 | 486 | 265 | 464 | -60 | 12 | -12 | -63 |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Technical Experience | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 1,324 | 2,559 | 1,343 | 2,631 | 993 | 1,831 | 1,004 | 1,941 | 240 | 538 | 275 | 523 | 119 | 210 | 85 | 186 | -28 | -20 | -20 | -20 |
| Investment Income | 1,967 | 3,731 | 2,088 | 3,988 | 1,427 | 2,625 | 1,512 | 2,864 | 366 | 761 | 422 | 794 | 202 | 365 | 174 | 350 | -28 | -20 | -20 | -20 |
| Insurance Finance Expenses | -643 | -1,172 | -745 | -1,358 | -434 | -794 | -508 | -922 | -126 | -223 | -148 | -272 | -83 | -155 | -90 | -163 | 0 | 0 | 0 | 0 |
| Other Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt Financing Charges | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings Before Tax | 4,006 | 7,565 | 4,202 | 8,040 | 2,843 | 5,203 | 2,973 | 5,557 | 886 | 1,674 | 913 | 1,914 | 365 | 696 | 349 | 650 | -87 | -8 | -33 | -82 |
| Tax | -1,046 | -1,952 | -1,074 | -2,060 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Income from Affiliates & Other | 2 | 3 | 1 | 3 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Minority Interests | -56 | -106 | -63 | -111 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings Group share | 2,908 | 5,510 | 3,067 | 5,872 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Closing Invested Assets | 113,515 | 118,104 | 116,895 | 117,507 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| o/w VFA | 0 | 0 | 0 | 0 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| o/w Non VFA | 113,515 | 118,104 | 116,895 | 117,507 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| For short-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Liabilities for remaining coverage net of reinsurance | 19,284 | 16,006 | 19,766 | 16,040 | 12,070 | 9,480 | 12,240 | 9,127 | 6,369 | 5,478 | 6,831 | 5,871 | 1,572 | 1,075 | 1,436 | 1,009 | -728 | -27 | -740 | 32 |
| Best Estimate for incurred Claims net of reinsurance | 69,800 | 71,751 | 70,215 | 70,567 | 45,710 | 46,570 | 46,591 | 47,002 | 17,809 | 18,308 | 17,781 | 17,402 | 6,704 | 6,830 | 6,290 | 6,198 | -423 | 43 | -447 | -35 |
P&C UE by Geography
Property & casualty underlying earnings build-up by geography
| EUR million | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | Transversal & Other | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | o/w AXA XL Insurance | FY24 | o/w AXA XL Insurance | 1H25 | o/w AXA XL Insurance | FY25 | o/w AXA XL Insurance | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 27,294 | 55,898 | 28,697 | 57,656 | 4,393 | 9,194 | 4,697 | 9,768 | 10,060 | 20,400 | 10,610 | 21,305 | 9,022 | 7,867 | 18,530 | 16,136 | 9,428 | 8,129 | 18,699 | 16,207 | 2,855 | 5,825 | 2,975 | 5,949 | 963 | 1,948 | 987 | 1,935 |
| Current Accident Year Loss Ratio | 67.0% | 67.7% | 66.7% | 66.9% | 69.4% | 68.9% | 70.6% | 70.1% | 66.5% | 66.9% | 64.7% | 65.1% | 67.5% | 67.2% | 69.2% | 69.0% | 68.4% | 68.0% | 68.8% | 68.3% | 68.6% | 69.3% | 68.2% | 69.6% | 53.2% | 51.0% | 48.0% | 44.6% |
| Undiscounted Current Accident Year Loss Ratio (excl. Nat Cats) | 67.4% | 67.4% | 67.0% | 67.0% | 71.3% | 69.7% | 70.6% | 70.2% | 65.0% | 65.5% | 64.1% | 64.3% | 68.8% | 68.9% | 69.3% | 69.5% | 69.7% | 69.8% | 69.8% | 69.6% | 70.0% | 70.4% | 69.7% | 70.2% | 52.9% | 51.1% | 48.0% | 44.5% |
| Undiscounted Current Accident Year Nat Cats | 3.6% | 3.8% | 3.5% | 3.4% | 3.4% | 3.8% | 4.8% | 4.5% | 4.5% | 4.1% | 3.3% | 3.1% | 3.8% | 2.8% | 4.6% | 3.8% | 4.2% | 3.4% | 3.9% | 3.1% | 0.8% | 0.9% | 0.8% | 1.6% | 1.4% | 1.1% | 1.3% | 1.2% |
| Current Accident Year Discounting | -3.9% | -3.6% | -3.9% | -3.5% | -5.3% | -4.6% | -4.8% | -4.6% | -3.1% | -2.8% | -2.7% | -2.3% | -5.1% | -4.6% | -4.7% | -4.2% | -5.5% | -5.2% | -4.9% | -4.4% | -2.2% | -2.0% | -2.3% | -2.2% | -1.1% | -1.2% | -1.2% | -1.1% |
| Prior Year Reserve Development Ratio | -1.5% | -1.6% | -1.1% | -1.1% | -3.5% | -3.9% | -2.6% | -2.9% | -2.1% | -2.1% | -1.1% | -1.3% | -0.1% | 0.0% | -0.1% | 0.0% | -0.2% | -0.2% | 0.0% | 0.0% | -0.1% | 0.1% | -1.0% | -0.2% | -3.7% | -5.7% | -4.0% | -1.9% |
| Expense Ratio | 24.7% | 25.0% | 24.5% | 24.8% | 21.9% | 21.9% | 20.7% | 20.4% | 25.9% | 26.2% | 26.0% | 26.2% | 20.3% | 21.8% | 21.0% | 22.7% | 20.4% | 22.2% | 20.9% | 22.6% | 29.4% | 29.6% | 29.0% | 29.8% | 50.5% | 50.9% | 52.5% | 52.8% |
| Combined Ratio | 90.2% | 91.0% | 90.0% | 90.6% | 87.8% | 86.8% | 88.6% | 87.5% | 90.3% | 91.0% | 89.6% | 90.0% | 87.7% | 89.0% | 90.2% | 91.7% | 88.6% | 90.0% | 89.7% | 91.0% | 98.0% | 99.1% | 96.2% | 99.2% | 100.1% | 96.2% | 96.5% | 95.5% |
| Technical Margin | 2,682 | 5,006 | 2,859 | 5,409 | 538 | 1,212 | 533 | 1,220 | 977 | 1,844 | 1,104 | 2,127 | 1,111 | 865 | 1,820 | 1,335 | 1,074 | 809 | 1,928 | 1,464 | 57 | 55 | 114 | 48 | -1 | 74 | 35 | 86 |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Technical Experience | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 1,324 | 2,559 | 1,343 | 2,631 | 251 | 421 | 261 | 468 | 473 | 912 | 461 | 876 | 273 | 159 | 596 | 387 | 298 | 213 | 632 | 445 | 242 | 484 | 261 | 530 | 86 | 146 | 62 | 125 |
| Investment Income | 1,967 | 3,731 | 2,088 | 3,988 | 334 | 572 | 373 | 675 | 658 | 1,244 | 667 | 1,257 | 614 | 416 | 1,233 | 868 | 681 | 507 | 1,331 | 981 | 261 | 518 | 292 | 585 | 100 | 164 | 74 | 140 |
| Insurance Finance Expenses | -643 | -1,172 | -745 | -1,358 | -83 | -151 | -112 | -207 | -185 | -332 | -206 | -381 | -341 | -257 | -637 | -481 | -384 | -294 | -699 | -536 | -20 | -35 | -31 | -55 | -14 | -18 | -12 | -15 |
| Other Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt Financing Charges | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings Before Tax | 4,006 | 7,565 | 4,202 | 8,040 | 788 | 1,633 | 794 | 1,688 | 1,450 | 2,757 | 1,564 | 3,002 | 1,384 | 1,024 | 2,417 | 1,721 | 1,372 | 1,022 | 2,560 | 1,910 | 299 | 539 | 375 | 579 | 85 | 220 | 97 | 211 |
| Tax | -1,046 | -1,952 | -1,074 | -2,060 | -249 | -472 | -220 | -451 | -352 | -671 | -384 | -734 | -352 | -257 | -588 | -457 | -339 | -252 | -647 | -482 | -77 | -159 | -110 | -170 | -15 | -62 | -21 | -58 |
| Income from Affiliates & Other | 2 | 3 | 1 | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 3 | 1 | 3 | 0 | 0 | 0 | 0 |
| Minority Interests | -56 | -106 | -63 | -111 | 0 | 0 | 0 | 0 | -25 | -57 | -28 | -52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -30 | -49 | -34 | -57 | 0 | 0 | -1 | -2 |
| Underlying Earnings Group share | 2,908 | 5,510 | 3,067 | 5,872 | 539 | 1,161 | 574 | 1,237 | 1,073 | 2,029 | 1,152 | 2,216 | 1,032 | 767 | 1,828 | 1,264 | 1,032 | 770 | 1,913 | 1,427 | 194 | 334 | 233 | 355 | 70 | 158 | 75 | 151 |
| For short-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Liabilities for remaining coverage net of reinsurance | 19,284 | 16,006 | 19,766 | 16,040 | 2,153 | 1,712 | 2,221 | 1,783 | 7,151 | 5,166 | 7,591 | 5,534 | 7,478 | 5,905 | 7,028 | 5,948 | 7,315 | 5,879 | 6,467 | 5,461 | 1,802 | 1,834 | 1,935 | 2,024 | 700 | 266 | 705 | 231 |
| Best Estimate for incurred Claims net of reinsurance | 69,800 | 71,751 | 70,215 | 70,567 | 13,485 | 13,889 | 13,900 | 13,882 | 24,834 | 25,955 | 26,003 | 25,737 | 24,865 | 18,223 | 25,915 | 19,146 | 24,533 | 18,295 | 25,044 | 18,897 | 3,385 | 3,640 | 3,510 | 3,804 | 3,231 | 2,351 | 2,269 | 2,101 |
L&H UE by LOB
Life & health underlying earnings build-up by line of business
| EUR million | Total | Life | Health | Employee Benefits* (out of Total Life & Health) (footnote: Employee Benefits include Group Protection and Group Health contracts.) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 7,979 | 16,207 | 8,512 | 17,416 | 2,112 | 4,247 | 2,211 | 4,444 | 5,867 | 11,960 | 6,301 | 12,972 | 5,592 | 11,482 | 5,931 | 12,035 |
| Combined Ratio | 97.6% | 97.4% | 97.1% | 97.2% | 94.5% | 95.5% | 95.2% | 95.4% | 98.6% | 98.1% | 97.8% | 97.9% | 98.2% | 97.8% | 97.4% | 97.1% |
| Technical Margin | 195 | 415 | 248 | 479 | 116 | 191 | 107 | 206 | 79 | 224 | 141 | 273 | 101 | 248 | 156 | 347 |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | 1,395 | 2,775 | 1,428 | 2,954 | 1,136 | 2,253 | 1,158 | 2,415 | 259 | 522 | 270 | 539 | 58 | 110 | 59 | 107 |
| Technical Experience | -64 | -95 | -30 | -150 | -71 | -98 | -28 | -139 | 7 | 3 | -2 | -11 | 17 | 37 | 22 | 38 |
| Actual vs. Expected Cash Flows | 9 | -15 | 12 | 39 | -4 | -33 | 10 | 37 | 13 | 18 | 2 | 2 | -3 | -2 | -5 | -8 |
| Risk Adjustment Release | 30 | 59 | 44 | 72 | 25 | 51 | 37 | 59 | 4 | 8 | 7 | 13 | 2 | 4 | 7 | 8 |
| Changes in Onerous Contracts | -32 | 6 | -12 | -29 | -30 | 9 | -10 | -25 | -1 | -2 | -2 | -4 | 0 | 0 | 0 | 0 |
| Other Long-term | -72 | -145 | -74 | -232 | -63 | -124 | -65 | -211 | -8 | -21 | -9 | -22 | 19 | 35 | 20 | 38 |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 536 | 975 | 563 | 946 | 454 | 799 | 462 | 738 | 82 | 176 | 101 | 209 | 75 | 157 | 91 | 175 |
| Investment Income | 1,319 | 2,525 | 1,329 | 2,484 | 1,159 | 2,209 | 1,159 | 2,142 | 160 | 317 | 170 | 341 | 219 | 429 | 232 | 456 |
| Insurance Finance Expenses | -783 | -1,551 | -767 | -1,538 | -705 | -1,410 | -697 | -1,405 | -78 | -140 | -69 | -133 | -144 | -272 | -141 | -281 |
| Other Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt Financing Charges | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings Before Tax | 2,061 | 4,070 | 2,209 | 4,229 | 1,634 | 3,145 | 1,699 | 3,219 | 427 | 925 | 510 | 1,010 | 252 | 552 | 328 | 666 |
| Tax | -412 | -874 | -462 | -800 | -316 | -635 | -329 | -584 | -96 | -239 | -133 | -216 | -46 | -111 | -64 | -110 |
| Income from Affiliates & Other | 103 | 186 | 101 | 157 | 101 | 182 | 93 | 154 | 2 | 4 | 8 | 2 | — | — | — | — |
| Minority Interests | -27 | -60 | -34 | -85 | -27 | -56 | -30 | -75 | 0 | -4 | -3 | -9 | — | — | — | — |
| Underlying Earnings Group share | 1,725 | 3,323 | 1,814 | 3,501 | 1,392 | 2,636 | 1,433 | 2,715 | 333 | 687 | 381 | 787 | 205 | 441 | 264 | 556 |
| Closing Invested Assets | 329,460 | 345,008 | 338,447 | 334,840 | — | — | — | — | — | — | — | — | — | — | — | — |
| o/w VFA | 234,783 | 230,205 | 229,844 | 226,937 | — | — | — | — | — | — | — | — | — | — | — | — |
| o/w Non VFA | 94,677 | 114,803 | 108,603 | 107,903 | — | — | — | — | — | — | — | — | — | — | — | — |
| For short-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Liabilities for remaining coverage net of reinsurance | 2,446 | 2,096 | 2,856 | 2,511 | 157 | 96 | 105 | 21 | 2,289 | 2,000 | 2,750 | 2,490 | — | — | — | — |
| Best Estimate for incurred Claims net of reinsurance | 13,876 | 14,162 | 13,960 | 14,592 | 11,589 | 11,778 | 11,623 | 11,205 | 2,286 | 2,384 | 2,337 | 3,386 | — | — | — | — |
| For long-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Best Estimate Liabilities net of reinsurance | 295,342 | 306,249 | 301,040 | 300,391 | 275,276 | 285,391 | 280,314 | 280,280 | 20,066 | 20,858 | 20,726 | 20,112 | — | — | — | — |
| o/w VFA Gross of reinsurance | 264,013 | 273,094 | 266,960 | 271,902 | 243,037 | 251,273 | 244,964 | 250,326 | 20,977 | 21,821 | 21,996 | 21,576 | — | — | — | — |
| o/w BBA Gross of reinsurance | 50,097 | 51,845 | 51,524 | 45,307 | 50,917 | 52,713 | 52,731 | 46,724 | -821 | -868 | -1,207 | -1,417 | — | — | — | — |
| o/w Reinsurance | -18,768 | -18,690 | -17,443 | -16,817 | -18,679 | -18,595 | -17,381 | -16,770 | -90 | -95 | -62 | -47 | — | — | — | — |
L&H UE by Geography
Life & health underlying earnings build-up by geography
| EUR million | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | Transversal & Other | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 7,979 | 16,207 | 8,512 | 17,416 | 4,654 | 9,503 | 4,870 | 9,787 | 1,778 | 3,604 | 2,051 | 4,419 | 0 | 0 | 0 | 0 | 1,457 | 2,925 | 1,503 | 3,037 | 90 | 174 | 88 | 172 |
| Combined Ratio | 97.6% | 97.4% | 97.1% | 97.2% | 96.7% | 97.3% | 97.4% | 97.3% | 98.8% | 96.9% | 96.4% | 94.8% | 0.0% | 0.0% | 0.0% | 0.0% | 99.1% | 99.1% | 97.6% | 101.3% | 92.2% | 89.1% | 83.6% | 86.7% |
| Technical Margin | 195 | 415 | 248 | 479 | 155 | 258 | 124 | 265 | 21 | 113 | 73 | 230 | 0 | 0 | 0 | 0 | 13 | 26 | 36 | -39 | 7 | 19 | 14 | 23 |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | 1,395 | 2,775 | 1,428 | 2,954 | 407 | 823 | 419 | 895 | 468 | 920 | 471 | 984 | 4 | 3 | 0 | 1 | 516 | 1,029 | 538 | 1,074 | 0 | 0 | 0 | 0 |
| Technical Experience | -64 | -95 | -30 | -150 | -40 | -96 | -37 | -81 | -11 | -8 | 8 | -70 | 3 | 2 | 0 | -5 | -17 | 7 | -1 | 6 | 0 | 0 | 0 | 0 |
| Actual vs. Expected Cash Flows | 9 | -15 | 12 | 39 | 8 | -8 | 2 | 15 | 5 | -11 | -11 | -6 | -2 | -3 | -1 | -6 | 0 | 8 | 22 | 35 | 0 | 0 | 0 | 0 |
| Risk Adjustment Release | 30 | 59 | 44 | 72 | 5 | 15 | 9 | 14 | 11 | 21 | 21 | 32 | 0 | 1 | 0 | 1 | 13 | 23 | 13 | 25 | 0 | 0 | 0 | 0 |
| Changes in Onerous Contracts | -32 | 6 | -12 | -29 | 0 | 0 | 0 | 0 | -33 | -25 | -13 | -36 | 5 | 5 | 0 | 0 | -3 | 26 | 1 | 7 | 0 | 0 | 0 | 0 |
| Other Long-term | -72 | -145 | -74 | -232 | -52 | -103 | -49 | -111 | 7 | 7 | 12 | -61 | 0 | 0 | 0 | 0 | -26 | -50 | -37 | -61 | 0 | 0 | 0 | 0 |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 536 | 975 | 563 | 946 | 100 | 192 | 118 | 197 | 284 | 504 | 269 | 477 | 10 | 19 | 10 | 20 | 142 | 260 | 165 | 250 | 0 | 0 | 0 | 2 |
| Investment Income | 1,319 | 2,525 | 1,329 | 2,484 | 370 | 701 | 370 | 703 | 490 | 916 | 478 | 889 | 13 | 27 | 14 | 27 | 446 | 882 | 467 | 862 | 0 | 0 | 0 | 2 |
| Insurance Finance Expenses | -783 | -1,551 | -767 | -1,538 | -270 | -509 | -252 | -507 | -206 | -412 | -209 | -411 | -3 | -7 | -4 | -8 | -303 | -622 | -301 | -612 | 0 | 0 | 0 | 0 |
| Other Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt Financing Charges | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings Before Tax | 2,061 | 4,070 | 2,209 | 4,229 | 622 | 1,176 | 624 | 1,276 | 762 | 1,529 | 821 | 1,622 | 17 | 25 | 10 | 16 | 654 | 1,322 | 739 | 1,291 | 7 | 19 | 14 | 25 |
| Tax | -412 | -874 | -462 | -800 | -106 | -220 | -100 | -237 | -180 | -376 | -176 | -285 | -3 | 0 | -2 | -4 | -123 | -277 | -182 | -272 | 0 | 0 | -1 | -4 |
| Income from Affiliates & Other | 103 | 186 | 101 | 157 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 100 | 177 | 101 | 157 | 0 | 0 | 0 | 0 |
| Minority Interests | -27 | -60 | -34 | -85 | 0 | 0 | 0 | 0 | -23 | -49 | -28 | -74 | 0 | 0 | 0 | 0 | -4 | -12 | -5 | -11 | 0 | 0 | 0 | 0 |
| Underlying Earnings Group share | 1,725 | 3,323 | 1,814 | 3,501 | 519 | 964 | 524 | 1,039 | 559 | 1,104 | 616 | 1,264 | 14 | 25 | 8 | 12 | 627 | 1,211 | 653 | 1,165 | 7 | 19 | 14 | 22 |
| For short-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Liabilities for remaining coverage net of reinsurance | 2,446 | 2,096 | 2,856 | 2,511 | 50 | -2 | 28 | -6 | 1,228 | 967 | 1,619 | 1,352 | 0 | 0 | 0 | 0 | 1,159 | 1,124 | 1,204 | 1,155 | 9 | 6 | 5 | 10 |
| Best Estimate for incurred Claims net of reinsurance | 13,876 | 14,162 | 13,960 | 14,592 | 12,589 | 12,831 | 12,443 | 12,850 | 773 | 871 | 1,015 | 1,186 | 0 | 0 | 0 | 0 | 501 | 447 | 487 | 541 | 13 | 14 | 15 | 15 |
| For long-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Best Estimate Liabilities net of reinsurance | 295,342 | 306,249 | 301,040 | 300,391 | 112,949 | 115,280 | 114,525 | 114,424 | 135,034 | 139,257 | 137,584 | 136,725 | 324 | 345 | 310 | 309 | 47,035 | 51,368 | 48,620 | 48,934 | 0 | 0 | 0 | 0 |
| o/w VFA Gross of reinsurance | 264,013 | 273,094 | 266,960 | 271,902 | 116,132 | 117,942 | 116,770 | 117,266 | 121,623 | 125,513 | 121,135 | 122,782 | 0 | 0 | 0 | 0 | 26,258 | 29,639 | 29,055 | 31,854 | 0 | 0 | 0 | 0 |
| o/w BBA Gross of reinsurance | 50,097 | 51,845 | 51,524 | 45,307 | 9,606 | 10,019 | 9,848 | 8,873 | 13,520 | 13,810 | 16,410 | 13,760 | 1,670 | 1,659 | 1,522 | 1,473 | 25,301 | 26,356 | 23,743 | 21,201 | 0 | 0 | 0 | 0 |
| o/w Reinsurance | -18,768 | -18,690 | -17,443 | -16,817 | -12,790 | -12,682 | -12,093 | -11,715 | -108 | -66 | 39 | 183 | -1,346 | -1,315 | -1,212 | -1,164 | -4,524 | -4,627 | -4,178 | -4,121 | 0 | 0 | 0 | 0 |
Life UE by Geography
Life underlying earnings build-up by geography
| EUR million | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | Transversal & Other | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 2,112 | 4,247 | 2,211 | 4,444 | 1,902 | 3,843 | 2,005 | 4,044 | 53 | 109 | 54 | 106 | 0 | 0 | 0 | 0 | 157 | 296 | 152 | 295 | 0 | 0 | 0 | 0 |
| Combined Ratio | 94.5% | 95.5% | 95.2% | 95.4% | 95.1% | 96.3% | 95.9% | 96.1% | 79.8% | 77.0% | 79.0% | 77.3% | 0.0% | 0.0% | 0.0% | 0.0% | 92.3% | 91.5% | 91.5% | 91.6% | 0.0% | 0.0% | 0.0% | 0.0% |
| Technical Margin | 116 | 191 | 107 | 206 | 93 | 141 | 83 | 158 | 11 | 25 | 11 | 24 | 0 | 0 | 0 | 0 | 12 | 25 | 13 | 25 | 0 | 0 | 0 | 0 |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | 1,136 | 2,253 | 1,158 | 2,415 | 407 | 823 | 419 | 895 | 390 | 759 | 386 | 804 | 4 | 3 | 0 | 1 | 336 | 669 | 353 | 715 | 0 | 0 | 0 | 0 |
| Technical Experience | -71 | -98 | -28 | -139 | -40 | -96 | -37 | -81 | -4 | 12 | 13 | -53 | 3 | 2 | 0 | -5 | -30 | -16 | -4 | 0 | 0 | 0 | 0 | 0 |
| Actual vs. Expected Cash Flows | -4 | -33 | 10 | 37 | 8 | -8 | 2 | 15 | 3 | -11 | -11 | -6 | -2 | -3 | -1 | -6 | -12 | -10 | 20 | 33 | 0 | 0 | 0 | 0 |
| Risk Adjustment Release | 25 | 51 | 37 | 59 | 5 | 15 | 9 | 14 | 12 | 23 | 20 | 30 | 0 | 1 | 0 | 1 | 8 | 13 | 8 | 14 | 0 | 0 | 0 | 0 |
| Changes in Onerous Contracts | -30 | 9 | -10 | -25 | 0 | 0 | 0 | 0 | -32 | -23 | -13 | -33 | 5 | 5 | 0 | 0 | -3 | 26 | 3 | 8 | 0 | 0 | 0 | 0 |
| Other Long-term | -63 | -124 | -65 | -211 | -52 | -103 | -49 | -111 | 13 | 23 | 17 | -44 | 0 | 0 | 0 | 0 | -23 | -45 | -34 | -55 | 0 | 0 | 0 | 0 |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 454 | 799 | 462 | 738 | 103 | 193 | 114 | 185 | 249 | 432 | 232 | 401 | 10 | 19 | 10 | 20 | 92 | 155 | 105 | 132 | 0 | 0 | 0 | 0 |
| Investment Income | 1,159 | 2,209 | 1,159 | 2,142 | 344 | 660 | 346 | 649 | 451 | 838 | 438 | 809 | 13 | 27 | 14 | 27 | 350 | 684 | 361 | 657 | 0 | 0 | 0 | 0 |
| Insurance Finance Expenses | -705 | -1,410 | -697 | -1,405 | -241 | -467 | -232 | -464 | -202 | -407 | -206 | -408 | -3 | -7 | -4 | -8 | -259 | -530 | -256 | -525 | 0 | 0 | 0 | 0 |
| Other Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt Financing Charges | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings Before Tax | 1,634 | 3,145 | 1,699 | 3,219 | 563 | 1,060 | 579 | 1,156 | 645 | 1,227 | 643 | 1,176 | 17 | 25 | 10 | 16 | 409 | 833 | 468 | 872 | 0 | 0 | 0 | 0 |
| Tax | -316 | -635 | -329 | -584 | -96 | -194 | -93 | -213 | -148 | -289 | -131 | -183 | -3 | 0 | -2 | -4 | -68 | -152 | -103 | -184 | 0 | 0 | 0 | 0 |
| Income from Affiliates & Other | 101 | 182 | 93 | 154 | 4 | 9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 97 | 173 | 93 | 154 | 0 | 0 | 0 | 0 |
| Minority Interests | -27 | -56 | -30 | -75 | 0 | 0 | 0 | 0 | -23 | -47 | -28 | -70 | 0 | 0 | 0 | 0 | -4 | -9 | -3 | -5 | 0 | 0 | 0 | 0 |
| Underlying Earnings Group share | 1,392 | 2,636 | 1,433 | 2,715 | 470 | 875 | 486 | 943 | 474 | 891 | 484 | 923 | 14 | 25 | 8 | 12 | 434 | 845 | 456 | 837 | 0 | 0 | 0 | 0 |
| For short-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Liabilities for remaining coverage net of reinsurance | 157 | 96 | 105 | 21 | 23 | -19 | 4 | -41 | -3 | -14 | -35 | -24 | 0 | 0 | 0 | 0 | 137 | 129 | 137 | 86 | 0 | 0 | 0 | 0 |
| Best Estimate for incurred Claims net of reinsurance | 11,589 | 11,778 | 11,623 | 11,205 | 11,349 | 11,502 | 11,352 | 10,939 | 75 | 120 | 118 | 124 | 0 | 0 | 0 | 0 | 165 | 157 | 154 | 142 | 0 | 0 | 0 | 0 |
| For long-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Best Estimate Liabilities net of reinsurance | 275,276 | 285,391 | 280,314 | 280,280 | 112,949 | 115,280 | 114,525 | 114,424 | 114,389 | 117,841 | 116,058 | 115,433 | 324 | 345 | 310 | 309 | 47,614 | 51,926 | 49,420 | 50,113 | 0 | 0 | 0 | 0 |
| o/w VFA Gross of reinsurance | 243,037 | 251,273 | 244,964 | 250,326 | 116,132 | 117,942 | 116,770 | 117,266 | 100,727 | 103,800 | 99,267 | 101,144 | 0 | 0 | 0 | 0 | 26,178 | 29,530 | 28,928 | 31,916 | 0 | 0 | 0 | 0 |
| o/w BBA Gross of reinsurance | 50,917 | 52,713 | 52,731 | 46,724 | 9,606 | 10,019 | 9,848 | 8,873 | 13,770 | 14,107 | 16,752 | 14,106 | 1,670 | 1,659 | 1,522 | 1,473 | 25,871 | 26,927 | 24,608 | 22,272 | 0 | 0 | 0 | 0 |
| o/w Reinsurance | -18,679 | -18,595 | -17,381 | -16,770 | -12,790 | -12,682 | -12,093 | -11,715 | -108 | -66 | 39 | 183 | -1,346 | -1,315 | -1,212 | -1,164 | -4,435 | -4,532 | -4,116 | -4,074 | 0 | 0 | 0 | 0 |
Health UE by Geography
Health underlying earnings build-up by geography
| EUR million | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | Transversal & Other | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 | 1H24 | FY24 | 1H25 | FY25 |
| Short-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Revenues | 5,867 | 11,960 | 6,301 | 12,972 | 2,752 | 5,661 | 2,865 | 5,744 | 1,725 | 3,495 | 1,997 | 4,314 | 0 | 0 | 0 | 0 | 1,300 | 2,629 | 1,350 | 2,742 | 90 | 174 | 88 | 172 |
| Combined Ratio | 98.6% | 98.1% | 97.8% | 97.9% | 97.8% | 97.9% | 98.5% | 98.1% | 99.4% | 97.5% | 96.9% | 95.2% | 0.0% | 0.0% | 0.0% | 0.0% | 100.0% | 100.0% | 98.3% | 102.3% | 92.2% | 89.1% | 83.6% | 86.7% |
| Technical Margin | 79 | 224 | 141 | 273 | 62 | 117 | 42 | 108 | 10 | 88 | 62 | 206 | 0 | 0 | 0 | 0 | 1 | 1 | 23 | -64 | 7 | 19 | 14 | 23 |
| Long-term Business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| CSM Release | 259 | 522 | 270 | 539 | 0 | 0 | 0 | 0 | 78 | 161 | 84 | 180 | 0 | 0 | 0 | 0 | 180 | 360 | 186 | 359 | 0 | 0 | 0 | 0 |
| Technical Experience | 7 | 3 | -2 | -11 | 0 | 0 | 0 | 0 | -6 | -20 | -5 | -17 | 0 | 0 | 0 | 0 | 14 | 23 | 3 | 6 | 0 | 0 | 0 | 0 |
| Actual vs. Expected Cash Flows | 13 | 18 | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 12 | 18 | 2 | 2 | 0 | 0 | 0 | 0 |
| Risk Adjustment Release | 4 | 8 | 7 | 13 | 0 | 0 | 0 | 0 | 0 | -2 | 1 | 3 | 0 | 0 | 0 | 0 | 5 | 10 | 5 | 11 | 0 | 0 | 0 | 0 |
| Changes in Onerous Contracts | -1 | -2 | -2 | -4 | 0 | 0 | 0 | 0 | -1 | -2 | 0 | -3 | 0 | 0 | 0 | 0 | -1 | 0 | -1 | -1 | 0 | 0 | 0 | 0 |
| Other Long-term | -8 | -21 | -9 | -22 | 0 | 0 | 0 | 0 | -6 | -16 | -6 | -16 | 0 | 0 | 0 | 0 | -2 | -5 | -3 | -5 | 0 | 0 | 0 | 0 |
| Financial Result & Other | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financial Result | 82 | 176 | 101 | 209 | -3 | -1 | 4 | 12 | 35 | 72 | 37 | 76 | 0 | 0 | 0 | 0 | 51 | 105 | 60 | 118 | 0 | 0 | 0 | 2 |
| Investment Income | 160 | 317 | 170 | 341 | 26 | 41 | 24 | 55 | 39 | 77 | 40 | 79 | 0 | 0 | 0 | 0 | 95 | 198 | 106 | 205 | 0 | 0 | 0 | 2 |
| Insurance Finance Expenses | -78 | -140 | -69 | -133 | -29 | -43 | -20 | -42 | -4 | -5 | -4 | -3 | 0 | 0 | 0 | 0 | -45 | -93 | -45 | -87 | 0 | 0 | 0 | 0 |
| Other Revenues | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Other Expenses | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt Financing Charges | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Underlying Earnings Before Tax | 427 | 925 | 510 | 1,010 | 59 | 116 | 46 | 120 | 117 | 302 | 178 | 446 | 0 | 0 | 0 | 0 | 245 | 489 | 272 | 419 | 7 | 19 | 14 | 25 |
| Tax | -96 | -239 | -133 | -216 | -10 | -27 | -7 | -24 | -31 | -87 | -46 | -101 | 0 | 0 | 0 | 0 | -55 | -125 | -80 | -88 | 0 | 0 | -1 | -4 |
| Income from Affiliates & Other | 2 | 4 | 8 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 4 | 8 | 2 | 0 | 0 | 0 | 0 |
| Minority Interests | 0 | -4 | -3 | -9 | 0 | 0 | 0 | 0 | 0 | -1 | 0 | -4 | 0 | 0 | 0 | 0 | 0 | -3 | -3 | -6 | 0 | 0 | 0 | 0 |
| Underlying Earnings Group share | 333 | 687 | 381 | 787 | 49 | 89 | 39 | 96 | 85 | 213 | 132 | 341 | 0 | 0 | 0 | 0 | 192 | 366 | 197 | 328 | 7 | 19 | 14 | 22 |
| For short-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Liabilities for remaining coverage net of reinsurance | 2,289 | 2,000 | 2,750 | 2,490 | 27 | 18 | 24 | 35 | 1,231 | 981 | 1,654 | 1,375 | 0 | 0 | 0 | 0 | 1,022 | 995 | 1,067 | 1,069 | 9 | 6 | 5 | 10 |
| Best Estimate for incurred Claims net of reinsurance | 2,286 | 2,384 | 2,337 | 3,386 | 1,240 | 1,329 | 1,091 | 1,911 | 698 | 751 | 898 | 1,062 | 0 | 0 | 0 | 0 | 336 | 290 | 334 | 398 | 13 | 14 | 15 | 15 |
| For long-term business | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Best Estimate Liabilities net of reinsurance | 20,066 | 20,858 | 20,726 | 20,112 | 0 | 0 | 0 | 0 | 20,645 | 21,416 | 21,527 | 21,291 | 0 | 0 | 0 | 0 | -579 | -557 | -800 | -1,180 | 0 | 0 | 0 | 0 |
| o/w VFA Gross of reinsurance | 20,977 | 21,821 | 21,996 | 21,576 | 0 | 0 | 0 | 0 | 20,896 | 21,713 | 21,868 | 21,637 | 0 | 0 | 0 | 0 | 81 | 109 | 128 | -62 | 0 | 0 | 0 | 0 |
| o/w BBA Gross of reinsurance | -821 | -868 | -1,207 | -1,417 | 0 | 0 | 0 | 0 | -250 | -297 | -342 | -346 | 0 | 0 | 0 | 0 | -571 | -571 | -866 | -1,071 | 0 | 0 | 0 | 0 |
| o/w Reinsurance | -90 | -95 | -62 | -47 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -90 | -95 | -62 | -47 | 0 | 0 | 0 | 0 |
Asset Management
Asset management opening AUM rollforward
| EUR million | 1H24 | FY24 | 1H25 | FY25 (footnote: AXA IM FY contribution presented in this document corresponds to its effective contribution to the Group’s results over the period of time when it was consolidated, i.e. until 1st July 2025.) | ||||
|---|---|---|---|---|---|---|---|---|
| — | Total | o/w Third Party | Total | o/w Third Party | Total | o/w Third Party | Total | o/w Third Party |
| Opening AUM (in Euro billion) | 843 | 332 | 843 | 332 | 879 | 356 | 879 | 356 |
| Net Inflows | 7 | -1 | 3 | 4 | -3 | -10 | -3 | -10 |
| Scope & Other | 0 | 10 | 2 | 21 | 0 | -6 | 0 | -6 |
| Market Effect | 12 | 10 | 26 | 21 | -3 | -6 | -3 | -6 |
| Currency Impact | -4 | 10 | 5 | 21 | -21 | -6 | -21 | -6 |
| Closing AUM (in Euro billion) | 859 | 340 | 879 | 356 | 853 | 341 | 853 | 341 |
| Alternatives | 227 | 86 | 229 | 90 | 233 | 95 | 233 | 95 |
| Core & Other | 532 | 254 | 551 | 266 | 528 | 246 | 528 | 246 |
| Asian Joint Ventures | 101 | — | 99 | — | 92 | — | 92 | — |
| Gross Revenues - After Intercompany Elimination | 787 | — | 1,701 | — | 875 | — | 875 | — |
| Gross Revenues - Before Intercompany Elimination | 937 | — | 2,004 | — | 1,018 | — | 1,018 | — |
| Management Fees | 679 | 385 | 1,425 | 773 | 724 | 439 | 724 | 439 |
| Performance Fees | 18 | 8 | 57 | 21 | 16 | 9 | 16 | 9 |
| Distribution Fees | 205 | — | 409 | — | 231 | — | 231 | — |
| Other | 35 | — | 112 | — | 46 | — | 46 | — |
| General Expenses | -698 | — | -1,493 | — | -793 | — | -793 | — |
| Distribution Fees Retroceded | -205 | — | -409 | — | -231 | — | -231 | — |
| Financial Result | 24 | — | 35 | — | 14 | — | 14 | — |
| Underlying Earnings Before Tax | 263 | — | 546 | — | 239 | — | 239 | — |
| Tax | -69 | — | -160 | — | -68 | — | -68 | — |
| Income from Affiliates & Other | 16 | — | 29 | — | 8 | — | 8 | — |
| Minority Interests | -6 | — | -13 | — | -4 | — | -4 | — |
| Underlying Earnings Group Share | 204 | — | 402 | — | 175 | — | 175 | — |
| Average Assets under Management (€bn) | 749 | — | 759 | — | 769 | — | 769 | — |
| Asset Management Fee bps | 18.1 bps | — | 18.8 bps | — | 18.8 bps | — | 18.8 bps | — |
| Underlying Cost Income Ratio | 67.3% | — | 68.0% | — | 71.4% | — | 71.4% | — |
Holdings
| EUR million | 1H24 | FY24 | 1H25 | FY25 |
|---|---|---|---|---|
| Financial Result | 181 | 402 | 228 | 422 |
| Other Revenues | 522 | 1,050 | 607 | 1,149 |
| Other Expenses | -925 | -1,986 | -1,075 | -2,107 |
| Debt Financing Charges | -471 | -948 | -452 | -928 |
| Underlying Earnings Before Tax | -693 | -1,482 | -692 | -1,464 |
| Tax | 100 | 324 | 101 | 284 |
| Income from Affiliates & Other | 0 | 0 | 0 | 0 |
| Minority Interests | 0 | 0 | 0 | 0 |
| Underlying Earnings Group share | -592 | -1,157 | -591 | -1,180 |
Holdings cash balance rollforward
| EUR billion | 1H24 | FY24 | 1H25 | FY25 |
|---|---|---|---|---|
| Opening Cash Balance at AXA SA (footnote: Includes liquid invested assets.) | — | 4.0 | — | 4.0 |
| Net cash remittance from subsidiaries (footnote: Includes exceptional cash remittances from the reinsurance treaties for the in-force Savings portfolio at AXA France (Euro +0.4 billion in 2024) and AXA Life Europe (Euro +0.2 billion in 2024).) | — | 7.7 | — | 7.5 |
| Property & Casualty | — | 4.0 | — | 5.1 |
| Life & Health | — | 3.6 | — | 2.5 |
| Asset Management & Other | — | 0.1 | — | 0.0 |
| Dividends | — | -4.4 | — | -4.6 |
| Share buy-backs (footnote: On top of annual share buy-back, includes Euro +3.5 billion share buy-back in 2025 to offset the earnings dilution resulting from the disposal of AXA IM and Euro +0.7 billion share buy-back in 2024 from the reinsurance treaties for the in-force Savings portfolio at AXA France (Euro +0.5 billion) and AXA Life Europe (Euro +0.2 billion).) | — | -1.8 | — | -4.7 |
| Holding costs and interests | — | -1.3 | — | -1.3 |
| Debt issuance | — | 0.1 | — | 1.6 |
| M&A and disposals | — | 0.0 | — | 3.8 |
| Other | — | -0.3 | — | -0.7 |
| Closing Cash Balance at AXA SA (footnote: Includes liquid invested assets.) | — | 4.0 | — | 5.6 |
Activity Indicators
Activity indicators by line of business build-up
| EUR million | 1H24 | FY24 | 1H25 | FY25 | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | Total | P&C | Life & Health | o/w Employee Benefits (footnote: Employee Benefits include Group Protection and Group Health contracts.) | Life | Health | Asset Management | Bank | Total | P&C | Life & Health | o/w Employee Benefits (footnote: Employee Benefits include Group Protection and Group Health contracts.) | Life | Health | Asset Management | Bank | Total | P&C | Life & Health | o/w Employee Benefits (footnote: Employee Benefits include Group Protection and Group Health contracts.) | Life | Health | Asset Management | Bank | Total | P&C | Life & Health | o/w Employee Benefits (footnote: Employee Benefits include Group Protection and Group Health contracts.) | Life | Health | Asset Management | Bank |
| Gross Written Premiums & Other Revenues | 59,872 | 32,522 | 26,505 | 6,673 | 17,419 | 9,086 | 787 | 57 | 110,316 | 56,514 | 51,983 | 12,167 | 34,497 | 17,486 | 1,701 | 118 | 64,251 | 34,097 | 29,230 | 7,223 | 19,081 | 10,149 | 875 | 49 | 115,524 | 58,038 | 56,512 | 12,867 | 37,499 | 19,014 | 875 | 99 |
| IFRS17/9 New Business Value (NBV) (a) | 1,206 | — | 1,206 | — | 953 | 253 | — | — | 2,264 | — | 2,264 | — | 1,792 | 473 | — | — | 1,189 | — | 1,189 | — | 928 | 260 | — | — | 2,233 | — | 2,233 | — | 1,747 | 486 | — | — |
| New Business Contractual Service Margin (NB CSM) | 1,131 | — | 1,131 | — | 919 | 213 | — | — | 2,169 | — | 2,169 | — | 1,770 | 399 | — | — | 1,184 | — | 1,184 | — | 950 | 234 | — | — | 2,199 | — | 2,199 | — | 1,822 | 377 | — | — |
| Other NBV (footnote: Includes expected profits from short term Life & Health business, carried by Life entities, Pure Investment Contracts, NBV from Equity method entities as well as New Business Loss Components and Margin ceded to reinsurers.) | 456 | — | 456 | — | 333 | 123 | — | — | 824 | — | 824 | — | 594 | 231 | — | — | 382 | — | 382 | — | 270 | 113 | — | — | 757 | — | 757 | — | 491 | 266 | — | — |
| Tax | -381 | — | -381 | — | -299 | -83 | — | — | -729 | — | -729 | — | -572 | -158 | — | — | -378 | — | -378 | — | -292 | -86 | — | — | -724 | — | -724 | — | -567 | -157 | — | — |
| Present Value of Expected Premiums (PVEP) (b) | 25,588 | — | 25,588 | — | 18,234 | 7,354 | — | — | 50,896 | — | 50,896 | — | 36,860 | 14,036 | — | — | 25,918 | — | 25,918 | — | 19,487 | 6,430 | — | — | 49,357 | — | 49,357 | — | 37,103 | 12,254 | — | — |
| IFRS17/9 NBV Margin (a)/(b) | 4.7% | — | 4.7% | — | 5.2% | 3.4% | — | — | 4.4% | — | 4.4% | — | 4.9% | 3.4% | — | — | 4.6% | — | 4.6% | — | 4.8% | 4.0% | — | — | 4.5% | — | 4.5% | — | 4.7% | 4.0% | — | — |
Activity indicators by geography build-up
| EUR million | 1H24 | FY24 | 1H25 | FY25 | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | AXA IM | Transversal & Other | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | AXA IM | Transversal & Other | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | AXA IM | Transversal & Other | Total | France | Europe | AXA XL | Asia, Africa & EME-LATAM | AXA IM | Transversal & Other |
| Gross Written Premiums & Other Revenues | 59,872 | 14,719 | 22,579 | 11,220 | 9,571 | 787 | 995 | 110,316 | 28,996 | 39,298 | 19,383 | 19,083 | 1,701 | 1,856 | 64,251 | 15,670 | 24,649 | 11,749 | 10,302 | 875 | 1,006 | 115,524 | 30,598 | 43,005 | 19,277 | 19,925 | 875 | 1,844 |
| IFRS17/9 New Business Value (NBV) (a) | 1,206 | 354 | 348 | — | 504 | — | — | 2,264 | 682 | 597 | — | 986 | — | — | 1,189 | 315 | 364 | — | 510 | — | — | 2,233 | 695 | 578 | — | 959 | — | — |
| New Business Contractual Service Margin (NB CSM) | 1,131 | 203 | 398 | — | 531 | — | — | 2,169 | 391 | 731 | — | 1,047 | — | — | 1,184 | 199 | 443 | — | 541 | — | — | 2,199 | 431 | 740 | — | 1,028 | — | — |
| Other NBV (footnote: Includes expected profits from short term Life & Health business, carried by Life entities, Pure Investment Contracts, NBV from Equity method entities as well as New Business Loss Components and Margin ceded to reinsurers.) | 456 | 275 | 50 | — | 131 | — | — | 824 | 528 | 49 | — | 247 | — | — | 382 | 225 | 28 | — | 129 | — | — | 757 | 506 | 12 | — | 239 | — | — |
| Tax | -381 | -123 | -100 | — | -158 | — | — | -729 | -237 | -184 | — | -309 | — | — | -378 | -109 | -107 | — | -161 | — | — | -724 | -242 | -174 | — | -308 | — | — |
| Present Value of Expected Premiums (PVEP) (b) | 25,588 | 12,301 | 6,317 | — | 6,971 | — | — | 50,896 | 25,370 | 11,831 | — | 13,695 | — | — | 25,918 | 11,662 | 6,843 | — | 7,413 | — | — | 49,357 | 22,858 | 12,651 | — | 13,847 | — | — |
| IFRS17/9 NBV Margin (a)/(b) | 4.7% | 2.9% | 5.5% | — | 7.2% | — | — | 4.4% | 2.7% | 5.0% | — | 7.2% | — | — | 4.6% | 2.7% | 5.3% | — | 6.9% | — | — | 4.5% | 3.0% | 4.6% | — | 6.9% | — | — |
Balance Sheet
Assets build-up
| EUR billion | FY24 | FY25 |
|---|---|---|
| Goodwill | 18.1 | 17.8 |
| Other intangible assets | 4.4 | 4.4 |
| Total Intangible assets | 22.6 | 22.2 |
| Investments in real estate properties | 29.2 | 27.8 |
| Financial investments | 418.2 | 401.8 |
| Unit-linked Assets | 90.1 | 97.2 |
| Total Investments from Insurance activities | 537.5 | 526.9 |
| Investments from Non-Insurance Activities | 18.5 | 16.6 |
| Equity Method investments | 1.5 | 1.5 |
| Assets Arising from Insurance and Reinsurance Contracts Held | 26.1 | 23.9 |
| Present Value of Future Cash Flows | 24.1 | 22.0 |
| Contractual Service Margin | 1.4 | 1.4 |
| Risk Adjustment | 0.5 | 0.5 |
| Receivables and Other Assets | 24.1 | 21.9 |
| Assets held for sale | 4.5 | 0.2 |
| Cash and cash equivalents | 19.0 | 22.2 |
| Total Assets | 653.8 | 635.5 |
| EUR billion | FY24 | FY25 |
|---|---|---|
| Shareholders' Equity group share | 49.9 | 47.2 |
| Non-controlling Interests | 2.5 | 2.4 |
| Shareholders’ equity | 52.5 | 49.6 |
| Financing debt | 14.4 | 15.8 |
| Liabilities arising from insurance contracts and investment contracts with discretionary participation features contracts | 477.0 | 470.4 |
| Present Value of Future Cash Flows | 438.4 | 432.6 |
| Contractual Service Margin | 35.3 | 34.7 |
| Risk Adjustment | 3.3 | 3.1 |
| Other Investment Contract Liabilities | 12.6 | 12.8 |
| Liabilities arising from insurance, reinsurance and investment contracts | 489.6 | 483.2 |
| Liabilities Arising from Non-Insurance Activities | 10.1 | 9.9 |
| Provisions for risks and charges | 4.9 | 4.6 |
| Payables and Other liabilities | 80.9 | 72.5 |
| Liabilities held for sale | 1.4 | 0.0 |
| Total Liabilities, Non-controlling Interests and Shareholders' Equity | 653.8 | 635.5 |
CSM rollforward
Contractual service margin rollforward, pre-tax and post-tax
| EUR million | FY23 Restated (footnote: Following the termination of the sale of a closed life and pensions portfolio at AXA Germany in 2024. It was classified as held for sale in 2023.) | New Business CSM | Underlying Return on inforce | CSM Release | Economic Variance | Operating Variance | Other (footnote: Including scope changes and FX.) | FY24 |
|---|---|---|---|---|---|---|---|---|
| Total Group (pre-tax) | 34,187 | 2,169 | 1,383 | -2,775 | -998 | 432 | -545 | 33,853 |
| P&C | 206 | 0 | 0 | 0 | 0 | 0 | 76 | 282 |
| Life | 26,200 | 1,770 | 1,172 | -2,253 | -890 | 363 | -534 | 25,826 |
| Health | 7,782 | 400 | 211 | -522 | -108 | 69 | -87 | 7,744 |
| Total Group (post-tax) | 26,777 | — | — | — | — | — | — | 26,320 |
Contractual service margin rollforward, pre-tax and post-tax
| EUR million | FY24 | New Business CSM | Underlying Return on inforce | CSM Release | Economic Variance | Operating Variance | Other (footnote: Including scope changes and FX.) | FY25 |
|---|---|---|---|---|---|---|---|---|
| Total Group (pre-tax) | 33,853 | 2,199 | 1,328 | -2,954 | 594 | -316 | -1,451 | 33,253 |
| P&C | 282 | 0 | 0 | 0 | 0 | 0 | -21 | 261 |
| Life | 25,826 | 1,822 | 1,150 | -2,415 | 487 | -526 | -903 | 25,442 |
| Health | 7,744 | 377 | 178 | -539 | 107 | 210 | -527 | 7,550 |
| Total Group (post-tax) | 26,320 | — | — | — | — | — | — | 25,864 |
Invested Assets
General account invested assets breakdown by asset class and rating
| EUR billion | Fair value | Asset Allocation % | o/w Participating | Duration gap | Fair Value by Rating | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| — | Fair value | Asset Allocation % | o/w Participating | Duration gap | Average rating1 (footnote: Corporate bonds not rated by external rating agencies are reallocated under AXA’s internal ratings: AAA: Euro 0.03billion, AA: Euro 1billion, A: Euro 1,2 billion, BBB: Euro 3.6 billion, Below investment grade: Euro 5 billion.) | AAA | AA | A | BBB | Below Investment Grade | Non Rated |
| General Account Invested Assets (footnote: Reflects the fair value of assets excluding the minority interest share in assets held in fully consolidated invested funds, hedging derivatives, Unit-linked assets and investments from non-insurance activities.) | 450 | — | 60% | -0.4 yr | — | — | — | — | — | — | — |
| Fixed Income | 345 | 77% | 60% | — | — | — | — | — | — | — | — |
| Government Bonds | 167 | 37% | 66% | — | AA | 27% | 31% | 28% | 10% | 2% | 2% |
| Corporate Bonds and Loans | 121 | 27% | 55% | — | A | 16% | 6% | 39% | 28% | 11% | — |
| Other Fixed Income | 56 | 13% | 52% | — | — | — | — | — | — | — | — |
| Asset Backed Securities (footnote: Includes 91% of CLOs.) | 25 | 6% | 48% | — | — | 54% | 28% | 10% | 3% | 1% | 4% |
| Mortgage Loans (footnote: Residential loans (Euro 16 billion), Agency Pools (Euro 8 billion), and Commercial & agricultural loans (Euro 7 billion).) | 31 | 7% | 56% | — | — | — | — | — | — | — | — |
| Real Estate | 41 | 9% | 63% | — | — | — | — | — | — | — | — |
| Infrastructure Equity | 10 | 2% | 64% | — | — | — | — | — | — | — | — |
| Listed Equities (footnote: Includes hedges. Listed equities excluding hedges at Euro 14 billion (basis for % of participating).) | 10 | 2% | 82% | — | — | — | — | — | — | — | — |
| Private Equity & Hedge Funds (footnote: Private Equity (Euro 17 billion), Hedge Funds (Euro 5 billion) and Non-listed Equities (Euro 1 billion).) | 23 | 5% | 55% | — | — | — | — | — | — | — | — |
| Cash | 19 | 4% | 50% | — | — | — | — | — | — | — | — |
| Policy Loans | 2 | 0% | 51% | — | — | — | — | — | — | — | — |
Supplementary Info on Asset
Government bonds breakdown by geographical exposure
| EUR billion | Fair Value | Belgium | France | Germany | Italy | Japan | Netherlands | Spain | Switzerland | United States | Other EU countries | Supranational | Rest of the World |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breakdown By Geographical Exposure | 167 | 6% | 12% | 6% | 5% | 8% | 3% | 6% | 9% | 10% | 8% | 13% | 15% |
Corporate bonds and loans breakdown by industry
| EUR billion | Fair Value | Basic Materials | Communications | Consumer, Cyclical | Consumer, Non-Cyclical | Covered and Senior Secured Bonds | Energy | Financials | Industrial | Technology | Utilities | Other |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breakdown By Industry | 121 | 2% | 6% | 4% | 11% | 29% | 1% | 28% | 6% | 2% | 8% | 3% |
Corporate bonds and loans exposure to financials by type {{footnote|1=Includes REITS corporate bonds (Euro 3 billion).}}
| EUR billion | Total | Banks | Non-Banks1 (footnote: Excludes banking operations and Euro 8 billion of Agency pools (Mortgage-backed securities issues by US Government Sponsored Enterprises).) |
|---|---|---|---|
| Total | 33.4 | 27.5 | 6.0 |
| Senior Unsecured Bonds | 29.8 | 24.3 | 5.5 |
| Subordinated Bonds (footnote: Includes AT1 (Euro 0.4 billion).) | 3.0 | 2.7 | 0.4 |
| Other | 0.6 | 0.5 | 0.1 |
Listed equities breakdown by asset domiciliation
| EUR billion | Fair Value | Belgium | France | Germany | Japan | Netherlands | Switzerland | United States | Other EU countries | Rest of the World |
|---|---|---|---|---|---|---|---|---|---|---|
| Breakdown By Asset Domiciliation | 10 | 3% | 7% | 3% | 7% | 2% | 4% | 37% | 9% | 27% |
Listed equities breakdown by industry {{footnote|1=Including hedges.}}
| EUR billion | Fair Value | Basic Materials | Communications | Consumer, Cyclical | Consumer, Non-Cyclical | Diversified | Energy | Financials | Funds | Industrial | Technology | Utilities | Other |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breakdown By Industry | 10 | 5% | 11% | 9% | 14% | 3% | 0% | 20% | 6% | 12% | 17% | 1% | 0% |
Real estate breakdown by geographical exposure
| EUR billion | Fair Value | Belgium | France | Germany | Italy | Japan | Spain | Switzerland | United Kingdom | United States | Other EU countries | Rest of the World |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breakdown By Geographical Exposure | 41 | 5% | 25% | 11% | 3% | 5% | 4% | 13% | 7% | 12% | 5% | 10% |
Real estate breakdown by type
| EUR billion | Fair Value | Office | Residential | Industrial-Logistic | Retail | Others |
|---|---|---|---|---|---|---|
| Breakdown By Type | 41 | 33% | 22% | 15% | 12% | 18% |
Private equities breakdown by asset domiciliation {{footnote|1=Excluding Non-listed Equity.}}
| EUR billion | Fair Value | Europe | Japan | United States | Other |
|---|---|---|---|---|---|
| Breakdown By Asset Domiciliation | 17 | 45% | 5% | 46% | 5% |
Mortgage loans breakdown by type
| EUR billion | Fair Value | Residential | Commercial (footnote: Loan to Value: 46%.) |
|---|---|---|---|
| Breakdown by Type | 23 | 69% | 31% |
| EUR billion | FY25 |
|---|---|
| Shareholders' Equity at Beginning of the Period | 49.9 |
| Paid-in Capital | -4.9 |
| Treasury Shares | -0.1 |
| Other Comprehensive Income Arising from Defined Benefit Plans | -0.3 |
| Fair Value Recorded in Shareholders' Equity | 1.3 |
| Other Comprehensive Income Related to Invested Assets | -4.2 |
| Other Comprehensive Income Related to (re) Insurance Contracts | 5.4 |
| Impact of Currency Fluctuations | -3.5 |
| Undated Subordinated Debt (including interest charges) | -0.3 |
| Realized Gains on Equity through Retained Earnings | 0.1 |
| Dividends | -4.6 |
| Net Income for the Period | 9.8 |
| Other | -0.2 |
| Shareholders' Equity at End of the Period | 47.2 |
| EUR billion | FY24 | FY25 |
|---|---|---|
| Paid-in Capital | 21.8 | 16.9 |
| Treasury Shares | -1.5 | -1.6 |
| Other Comprehensive Income Arising from Defined Benefit Plans | -2.4 | -2.8 |
| Other Comprehensive Income | -8.1 | -6.8 |
| Other Comprehensive Income Related to Invested Assets | -13.1 | -17.3 |
| Other Comprehensive Income Related to (re) Insurance Contracts | 5.0 | 10.5 |
| Translation Reserves | -1.1 | -4.6 |
| Undated Subordinated Debt | 4.8 | 4.6 |
| Retained Earnings | 36.5 | 41.4 |
| Total Shareholders' Equity at the End of the Period | 49.9 | 47.2 |
| EUR | FY24 | FY25 |
|---|---|---|
| Book Value per Share (footnote: Shareholders' equity excludes the other comprehensive income as well as the undated and deeply subordinated debt.) | 24.5 | 24.0 |
| Shareholders' Equity + CSM per Share (footnote: Shareholders' equity excludes the undated and deeply subordinated debt. CSM is net of tax and Group Share.) | 32.7 | 33.2 |
Unrealized gains and losses on invested assets net of tax build-up
| EUR billion | FY24 | FY25 |
|---|---|---|
| Government Bonds (recyclable) | -7.5 | -13.0 |
| Corporate Bonds (recyclable) | -4.1 | -3.0 |
| Cash Flow hedges (recyclable) | -3.5 | -3.3 |
| Equities (non-recyclable) | 2.3 | 2.1 |
| Others (recyclable) | -0.3 | -0.1 |
| Total Other Comprehensive Income Related to Invested Assets | -13.1 | -17.3 |
| Real Estate | 6.7 | 6.5 |
| Other Invested Assets Not Included in Shareholders' Equity | -0.6 | -0.1 |
| Total Unrealized Gains and Losses on Invested Assets at Cost (Net of Tax) | 6.1 | 6.4 |
| Total Unrealized Gains and Losses on Invested Assets (Net of Tax) | -7.0 | -10.9 |
RoE & Gearing
Return on equity by type
| EUR billion | FY24 | FY25 | Change in % points (FY25 vs FY24) |
|---|---|---|---|
| Net Income ROE | 14.8% | 18.8% | 3.9 pt |
| Net Income (footnote: Including adjustments to reflect net financial charges related to undated and deeply subordinated debt (recorded through shareholders' equity).) | 7.7 | 9.6 | — |
| Average Adjusted Shareholders' Equity (footnote: Excluding reserves for Other Comprehensive Income as well as undated and deeply subordinated debt (recorded through shareholders' equity).) | 51.8 | 51.3 | — |
| Underlying ROE | 15.2% | 16.0% | 0.8 pt |
| Underlying Earnings (footnote: Including adjustments to reflect net financial charges related to undated and deeply subordinated debt (recorded through shareholders' equity).) | 7.9 | 8.2 | — |
| Average Adjusted Shareholders' Equity (footnote: Excluding reserves for Other Comprehensive Income as well as undated and deeply subordinated debt (recorded through shareholders' equity).) | 51.8 | 51.3 | — |
Debt gearing build-up
| EUR billion | FY24 | FY25 |
|---|---|---|
| Financing Debt | 3.2 | 3.2 |
| Financing Debt Instrument Issued | 3.2 | 3.2 |
| Financing Debt Owed to Credit Institutions | 0.0 | 0.0 |
| Dated Subordinated Debt | 11.2 | 12.6 |
| Reversal of mark-to-market of interest rates derivatives | -0.1 | -0.1 |
| Total Gross Debt (A) | 14.3 | 15.7 |
| Undated Deeply Subordinated Notes (TSS) | 2.9 | 4.3 |
| Deeply Subordinated Notes (TSDI) | 1.9 | 0.3 |
| Total Gross Debt incl. Undated and Deeply Subordinated Notes (B) | 19.2 | 20.3 |
| Shareholders' Equity (Including Non-Controlling Interests) (a) (C) (footnote: Shareholders' equity includes undated and deeply subordinated debts.) | 52.5 | 49.6 |
| Contractual Service Margin net of tax (D) | 26.3 | 25.9 |
| Shareholders' Equity + Contractual Service Margin + Gross Debt (E) = (C) + (D) + (A) | 93.1 | 91.1 |
| Debt Gearing (G) = (B) / (E) | 20.6% | 22.3% |
Information on Solvency II
Solvency II rollforward
| EUR billion | FY24 | Regulatory & model changes | Normalized Capital Generation | Operating variance | Economic variance (incl. FX) | Dividend & share buy-backs | Debt | M&A, In-force and Other | FY25 |
|---|---|---|---|---|---|---|---|---|---|
| Eligible Own Fund (EOF) | 55.9 | 0.2 | 8.8 | -0.4 | -2.1 | -6.0 | 1.6 | -1.7 | 56.4 |
| Solvency Capital Requirement (SCR) | 25.9 | 0.0 | 0.6 | 0.0 | -1.2 | 0.0 | 0.0 | -0.2 | 25.2 |
| Solvency II Ratio | 216% | 0% | 28% | -1% | 4% | -24% | 6% | -5% | 224% |
Eligible own fund tiering by sector
| EUR billion | Total | Unrestricted Tier 1 | Restricted Tier 1 | Tier 2 | Tier 3 |
|---|---|---|---|---|---|
| EOF as of FY25 | 56.4 | 39.6 | 4.7 | 11.6 | 0.4 |
| Insurance Sector | 55.1 | 38.4 | 4.7 | 11.6 | 0.4 |
| Ancillary | — | — | — | — | — |
| Subject to Transitional Measures (footnote: Transitional measures on basic own funds applied on subordinated debts eligible under Solvency I regulation. These subordinated debts were also eligible under Solvency II until December 31, 2025. They are no longer eligible since January 1, 2026.) | 2.4 | — | 1.4 | 1.0 | — |
| Other Financial Sectors | 1.2 | 1.2 | — | — | — |
| EOF as of FY24 | 55.9 | 40.0 | 4.9 | 10.2 | 0.8 |
| Insurance Sector | 53.5 | 37.5 | 4.9 | 10.2 | 0.8 |
| Ancillary | — | — | — | — | — |
| Subject to Transitional Measures (footnote: Transitional measures on basic own funds applied on subordinated debts eligible under Solvency I regulation. These subordinated debts were also eligible under Solvency II until December 31, 2025. They are no longer eligible since January 1, 2026.) | 4.5 | — | 3.4 | 1.1 | — |
| Other Financial Sectors | 2.5 | 2.5 | — | — | — |
Solvency II key sensitivities
| EUR billion | FY24 | FY25 |
|---|---|---|
| Interest Rate +50 bps | +2 pts | +2 pts |
| Interest Rate -50 bps | -4 pts | -1 pt |
| Corporate Spread +50bps | -1 pt | -1 pt |
| Euro Government Spreads +50bps | -10 pts | -7 pts |
| Credit Migration +20% | -4 pts | -4 pts |
| Listed Equities +25% | +0 pt | -1 pt |
| Listed Equities -25% | -3 pts | +2 pts |
| Private and Infrastructure Equity +25% | +13 pts | +14 pts |
| Private and Infrastructure Equity -25% | -15 pts | -19 pts |
| Inflation swap curve +50bps | -6 pts | -5 pts |
IFRS17 SHE to Group EOF
| EUR billion | FY25 |
|---|---|
| IFRS SHAREHOLDERS' EQUITY | 49.6 |
| Contractual Service Margin (net of tax) | 25.9 |
| IFRS SHAREHOLDERS' EQUITY inc. CSM | 75.5 |
| Net URCG not included in Shareholders' Equity | 6.4 |
| Elimination Undated Subordinated Debts | -4.6 |
| Elimination Intangibles | -21.3 |
| Goodwill | -17.8 |
| others | -3.5 |
| IFRS TANGIBLE NET ASSET VALUE | 56.0 |
| Foreseeable dividends and distribution | -6.3 |
| Technical provision adjustments | -9.6 |
| Risk Margin vs Risk Adjustment | -6.4 |
| BEL adjustment | -3.2 |
| Other adjustments | -0.6 |
| UNRESTRICTED TIER 1 | 39.6 |
| Restricted Tier 1 + Tier 2 | 16.4 |
| Tier 3 | 0.4 |
| GROUP ELIGIBLE OWN FUNDS | 56.4 |